US20210171783A1 - Zwitteronic double network hydrogels - Google Patents
Zwitteronic double network hydrogels Download PDFInfo
- Publication number
- US20210171783A1 US20210171783A1 US17/268,310 US201917268310A US2021171783A1 US 20210171783 A1 US20210171783 A1 US 20210171783A1 US 201917268310 A US201917268310 A US 201917268310A US 2021171783 A1 US2021171783 A1 US 2021171783A1
- Authority
- US
- United States
- Prior art keywords
- network
- zwitterionic
- poly
- hydrogel
- crosslinked
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 246
- 238000000034 method Methods 0.000 claims abstract description 28
- 229920000642 polymer Polymers 0.000 claims description 105
- 239000000178 monomer Substances 0.000 claims description 98
- -1 poly(sulfobetaine) Polymers 0.000 claims description 94
- 239000003999 initiator Substances 0.000 claims description 41
- 239000004971 Cross linker Substances 0.000 claims description 30
- 238000006116 polymerization reaction Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 229920001577 copolymer Polymers 0.000 claims description 19
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 18
- 239000002953 phosphate buffered saline Substances 0.000 claims description 18
- 229920006037 cross link polymer Polymers 0.000 claims description 15
- 230000008961 swelling Effects 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 11
- 229940012952 fibrinogen Drugs 0.000 claims description 11
- 102000008946 Fibrinogen Human genes 0.000 claims description 10
- 108010049003 Fibrinogen Proteins 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000004132 cross linking Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- 239000002243 precursor Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 210000004204 blood vessel Anatomy 0.000 claims description 6
- 210000003709 heart valve Anatomy 0.000 claims description 6
- 230000003993 interaction Effects 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 238000007334 copolymerization reaction Methods 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 230000008439 repair process Effects 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 229920002307 Dextran Polymers 0.000 claims description 3
- 208000010412 Glaucoma Diseases 0.000 claims description 3
- 229920000615 alginic acid Polymers 0.000 claims description 3
- 235000010443 alginic acid Nutrition 0.000 claims description 3
- 210000001367 artery Anatomy 0.000 claims description 3
- 239000002473 artificial blood Substances 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 239000004053 dental implant Substances 0.000 claims description 3
- 150000004676 glycans Chemical class 0.000 claims description 3
- 229920002674 hyaluronan Polymers 0.000 claims description 3
- 210000003041 ligament Anatomy 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 210000005036 nerve Anatomy 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 230000001172 regenerating effect Effects 0.000 claims description 3
- 210000002435 tendon Anatomy 0.000 claims description 3
- 239000003106 tissue adhesive Substances 0.000 claims description 3
- 229940075469 tissue adhesives Drugs 0.000 claims description 3
- 239000002407 tissue scaffold Substances 0.000 claims description 3
- 230000002792 vascular Effects 0.000 claims description 3
- 230000002861 ventricular Effects 0.000 claims description 3
- 229910021645 metal ion Inorganic materials 0.000 claims description 2
- 238000000159 protein binding assay Methods 0.000 claims description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 1
- 229940072056 alginate Drugs 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 24
- 238000012360 testing method Methods 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 238000002513 implantation Methods 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 150000001204 N-oxides Chemical class 0.000 description 8
- 239000003431 cross linking reagent Substances 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 239000007943 implant Substances 0.000 description 7
- 238000009864 tensile test Methods 0.000 description 7
- 238000003556 assay Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000012669 compression test Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 229940117986 sulfobetaine Drugs 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 5
- 125000005647 linker group Chemical group 0.000 description 5
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 5
- 238000010526 radical polymerization reaction Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 4
- 241000206761 Bacillariophyta Species 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000002843 lactate dehydrogenase assay Methods 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 125000005496 phosphonium group Chemical group 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 3
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 3
- 241000892895 Navicula salinicola Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 241000196252 Ulva Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000010560 atom transfer radical polymerization reaction Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000021164 cell adhesion Effects 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011737 fluorine Chemical group 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 210000004623 platelet-rich plasma Anatomy 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 230000010069 protein adhesion Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid group Chemical group S(O)(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 description 2
- YOCIJWAHRAJQFT-UHFFFAOYSA-N 2-bromo-2-methylpropanoyl bromide Chemical compound CC(C)(Br)C(Br)=O YOCIJWAHRAJQFT-UHFFFAOYSA-N 0.000 description 2
- BCAIDFOKQCVACE-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propane-1-sulfonate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCCS([O-])(=O)=O BCAIDFOKQCVACE-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 231100000416 LDH assay Toxicity 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 0 [1*][N+]([2*])([O-])*B(C)C Chemical compound [1*][N+]([2*])([O-])*B(C)C 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000010191 image analysis Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 150000003141 primary amines Chemical group 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000013535 sea water Substances 0.000 description 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 125000000565 sulfonamide group Chemical group 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-O sulfonium group Chemical group [SH3+] RWSOTUBLDIXVET-UHFFFAOYSA-O 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 150000003512 tertiary amines Chemical group 0.000 description 2
- UYPYRKYUKCHHIB-UHFFFAOYSA-N trimethylamine N-oxide Chemical compound C[N+](C)(C)[O-] UYPYRKYUKCHHIB-UHFFFAOYSA-N 0.000 description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 2
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- RUMACXVDVNRZJZ-UHFFFAOYSA-N 2-methylpropyl 2-methylprop-2-enoate Chemical compound CC(C)COC(=O)C(C)=C RUMACXVDVNRZJZ-UHFFFAOYSA-N 0.000 description 1
- KFNGWPXYNSJXOP-UHFFFAOYSA-N 3-(2-methylprop-2-enoyloxy)propane-1-sulfonic acid Chemical compound CC(=C)C(=O)OCCCS(O)(=O)=O KFNGWPXYNSJXOP-UHFFFAOYSA-N 0.000 description 1
- CSWRCKVZMMKVDC-UHFFFAOYSA-N 3-[dimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azaniumyl]propanoate Chemical compound CC(=C)C(=O)OCC[N+](C)(C)CCC([O-])=O CSWRCKVZMMKVDC-UHFFFAOYSA-N 0.000 description 1
- CYUZOYPRAQASLN-UHFFFAOYSA-N 3-prop-2-enoyloxypropanoic acid Chemical compound OC(=O)CCOC(=O)C=C CYUZOYPRAQASLN-UHFFFAOYSA-N 0.000 description 1
- WIYVVIUBKNTNKG-UHFFFAOYSA-N 6,7-dimethoxy-3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C1CC(C(O)=O)=CC2=C1C=C(OC)C(OC)=C2 WIYVVIUBKNTNKG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical group O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000893983 Ulva linza Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 150000001253 acrylic acids Chemical class 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 150000008064 anhydrides Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003262 carboxylic acid ester group Chemical group [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000003352 cell adhesion assay Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000000804 electron spin resonance spectroscopy Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229940106780 human fibrinogen Drugs 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229960001929 meloxicam Drugs 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000005395 methacrylic acid group Chemical class 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000002092 orthoester group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 125000002270 phosphoric acid ester group Chemical group 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012712 reversible addition−fragmentation chain-transfer polymerization Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000012289 standard assay Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- RRHXZLALVWBDKH-UHFFFAOYSA-M trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CC(=C)C(=O)OCC[N+](C)(C)C RRHXZLALVWBDKH-UHFFFAOYSA-M 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/16—Antifouling paints; Underwater paints
- C09D5/1656—Antifouling paints; Underwater paints characterised by the film-forming substance
- C09D5/1662—Synthetic film-forming substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/08—Materials for coatings
- A61L29/085—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/145—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F267/00—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated polycarboxylic acids or derivatives thereof as defined in group C08F22/00
- C08F267/10—Macromolecular compounds obtained by polymerising monomers on to polymers of unsaturated polycarboxylic acids or derivatives thereof as defined in group C08F22/00 on to polymers of amides or imides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L51/00—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
- C08L51/003—Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D151/00—Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers
- C09D151/003—Coating compositions based on graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Coating compositions based on derivatives of such polymers grafted on to macromolecular compounds obtained by reactions only involving unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/16—Antifouling paints; Underwater paints
- C09D5/1606—Antifouling paints; Underwater paints characterised by the anti-fouling agent
- C09D5/1637—Macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2300/00—Characterised by the use of unspecified polymers
- C08J2300/20—Polymers characterized by their physical structure
- C08J2300/208—Interpenetrating networks [IPN]
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
- C08J2333/14—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/18—Homopolymers or copolymers of nitriles
- C08J2333/22—Homopolymers or copolymers of nitriles containing four or more carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2381/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing sulfur with or without nitrogen, oxygen, or carbon only; Polysulfones; Derivatives of such polymers
- C08J2381/10—Polysulfonamides; Polysulfonimides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2433/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2433/04—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters
- C08J2433/14—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers esters of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2433/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2433/18—Homopolymers or copolymers of nitriles
- C08J2433/22—Homopolymers or copolymers of nitriles containing four or more carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2433/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2433/24—Homopolymers or copolymers of amides or imides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2477/00—Characterised by the use of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Derivatives of such polymers
Definitions
- Hydrogels with three-dimensional crosslinked networks and high capacity of water are of interest because of their potential in biomedical applications, such as biosensor devices, tissue implants, and contact lenses or marine applications, such as ship hulls, marine structures, marine sensors and fishing nets.
- Hydrogels made from zwitterionic materials are further of high interest for their superhydrophilicity and excellent non-fouling properties that prevent complications and device failure by resisting nonspecific biofouling from proteins, cells, and micro-organisms.
- Tg glass transition temperature
- the present invention provides zwitterionic double network hydrogels, methods for making zwitterionic double network hydrogels, methods for using zwitterionic double network hydrogels, and articles made from and coated with zwitterionic double network hydrogels.
- the invention provides zwitterionic double network hydrogels.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- a second chemical polymeric network comprising a second zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- a first polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties, wherein the first crosslinked zwitterionic polymer is not a poly(sulfobetaine);
- a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- a second polymeric network comprising a crosslinked poly(sulfobetaine) having from about 50 to about 100 mole percent zwitterionic moieties, wherein the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- the invention provides methods for making the zwitterionic double network hydrogels.
- the method is a two-step method.
- the method is a one-step (single-pot) process.
- articles of manufacture made from or that include the zwitterionic double network hydrogel are provided.
- FIG. 1 is a schematic illustration of the preparation of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel.
- ZDN zwitterionic double network
- FIG. 2A compare the swelling behaviors of the as-prepared pCB/pSB ZDN hydrogel and the swollen (fully equilibrated) ZDN hydrogel after soaking in DI water. Hydrogels were made according to the composition of 1-4-0.1/4-0.1-0.01.
- FIG. 2B compares equilibrium swelling ratios (%) and equilibrium water content (%) of pCB/pSB ZDN hydrogels with three (3) zwitterionic single network [ZSN1 (1-2-0.1, 1-4-0.1, and 2-4-0.1)] and seven (7) zwitterionic single network [ZSN2 (4-0-0.01, 4-0.01-0.01, 4-0.1-0.01, 4-0.2-0.01, 4-0.5-0.01, 2-0.1-0.01, and 6-0.1-0.01)] component ratios.
- FIGS. 3A-3C compare compressive fracture stress ( 3 A), compressive fracture strain ( 3 B), and compressive modulus ( 3 C) of representative pCB/pSB ZDN hydrogels with three (3) different pCB ZSN1 (1-2-0.1, 1-4-0.1, and 2-4-0.1) and seven (7) pSB ZSN2 (2-0.1-0.01, 4-0-0.01, 4-0.01-0.01, 4-0.1-0.01, 4-0.2-0.01, 4-0.5-0.01, and 6-0.1-0.01) component ratios.
- FIG. 4 compares the mass percentage of representative pCB/pSB ZDN hydrogels with three (3) different pCB ZSN1 (1-2-0.1, 1-4-0.1, and 2-4-0.1) and seven (7) pSB ZSN2 (2-0.1-0.01, 4-0-0.01, 4-0.01-0.01, 4-0.1-0.01, 4-0.2-0.01, 4-0.5-0.01, and 6-0.1-0.01) component ratios.
- FIGS. 5A and 5B compare representative uniaxial compressive curves ( 5 A) and compressive modulus, fracture stress, and fracture strain ( 5 B) of representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01), a pCB single network (SN) hydrogel (1-4-0.1), and a pSB single network (SN) hydrogel (4-0.1-0.01).
- FIGS. 6A and 6B compare representative tensile curves ( 6 A) and tensile modulus, fracture stress, and fracture strain ( 6 B) of representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01), a pCB single network hydrogel (SN, 1-4-0.1) and a pSB single network hydrogel (SN, 4-0.1-0.01).
- FIGS. 7A-7F compare relative nonfouling (protein and cell adhesion) of representative zwitterionic double network (pCB/pSB ZDN) hydrogel (1-4-0.1/4-0.1-0.01) surfaces: human fibrinogen ( 7 A), proteins in undiluted human serum ( 7 B), rat platelets ( 7 C), RIN-m5F cells ( 7 D), and DC 2.4 cells ( 7 E). All the data were normalized with respect to tissue culture polystyrene (TCPS). Optical images of RIN-m5F cells and DC 2.4 cells respectively adhered on TCPS and pCB/pSB ZDN hydrogel surfaces are compared in FIG. 7F . The magnification of all images was 200 ⁇ .
- TCPS tissue culture polystyrene
- FIGS. 8A-8D compare relative nonfouling (protein and cell adhesion) of representative zwitterionic double network (pCB/pSB ZDN) hydrogel (1-4-0.1/4-0.1-0.01) surfaces after three rounds of autoclaving (ZDN-R1, ZDN-R2 and ZDN-R3): proteins in undiluted human serum ( 8 A), rat platelets ( 8 B), RIN-m5F cells ( 8 C), and DC 2.4 cells ( 8 D). All the data were normalized with respect to TCPS.
- FIGS. 9A-9C compare hemotoxylin and eosin (H&E) staining for skin tissues with a representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01) after one week of implantation compared to pHEMA and Control ( 9 A); Masson's trichrome staining for skin tissues with a representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01) after implantation for 1, 4, and 12 weeks compared to pHEMA; images of implanted mice and retrieved representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01) and Masson's trichrome staining for skin tissues with pCB/pSB ZDN hydrogels after implantation for 24 weeks. Skin tissues of mice without implants were set as control. The magnification of all tissue staining images was 100 ⁇ .
- FIG. 10 compares degradation (weight remaining) and mechanical properties (compressive modulus remaining, compressive stress remaining, compressive strain remaining) of representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01) after implantation for 12 weeks.
- FIGS. 11A-11C compare compressive stress curves ( 11 A), compressive modulus, fracture stress, and fracture strain ( 11 B), and equilibrium swelling ratios and equilibrium water contents for representative ZDN hydrogels of the invention: pCB/pSB, pCB/pCB, pSB/pCB, pSB/pSB ZDN hydrogels.
- pCB/pSB and pSB/pSB ZDN hydrogels were made according to the composition of 1-4-0.1/4-0.1-0.01 and pCB/pCB and pSB/pCB ZDN hydrogels were made according to the composition of 1-4-0.1/4-0.2-0.01.
- FIGS. 12A-12C compare compression tests of representative ZDN hydrogels: pSB/pSB ( 12 A), pCB/CB ( 12 B), and pSB/CB ( 12 C).
- the first networks of ZDN hydrogels were made according to the composition of 1-4-0.1.
- the second networks of the ZDN hydrogels were made according to the seven (7) different compositions as indicated in the figure.
- FIGS. 15A-15C compare attachment and adhesion tests of Ulva spores on a representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), glass, and PDMS: density (number/mm 2 ) of attached spores after 45 minutes settlement followed by washing ( 15 A); removal (%) of spores due to washing and exposure to a shear stress of 52 Pa ( 15 B); and density (number/mm 2 ) of spores remaining after washing and exposure to a shear stress of 52 Pa ( 15 C). Each point is the mean from 90 counts on 3 replicate slides. Bars show 95% confidence limits derived from arc-sine transformed data.
- FIG. 16 compares compressive stress (MPa) and compressive strain (%) for a representative pTMAO/pSB ZDN hydrogel.
- the first network was made according to the composition 1-4-0.1 and the second network was made according the composition 4-0.1-0.01.
- the present invention provides zwitterionic double network hydrogels, methods for making zwitterionic double network hydrogels, methods for using zwitterionic double network hydrogels, and articles made from and coated with zwitterionic double network hydrogels.
- the invention provides zwitterionic double network hydrogels.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- crosslinked refers to both chemically crosslinked physically crosslinked polymers, unless otherwise stated.
- the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa. In certain of these embodiments, the compressive fracture stress of greater than about 2, 3, 5, 8, 10, 12, or 15 MPa.
- the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa
- the double network hydrogel may also be characterized as having a tensile fracture stress greater than about 0.3 MPa (e.g., greater than about 0.5, 0.7, or 1.0 MPa), a tensile fracture strain greater than about 200% (e.g., greater than about 250% or 300%), or a Young's modulus greater than about 0.01 MPa (e.g., greater than about 0.1, 0.5, 1.0 MPa).
- the term “zwitterionic polymer” refers to a polymer prepared by polymerizing a polymerizable zwitterionic monomer, which provides a zwitterionic polymer having 100 mole percent zwitterionic moieties (i.e., each repeating unit of the zwitterionic polymer is a zwitterionic moiety); or refers to a polymer prepared by copolymerizing a polymerizable zwitterionic monomer and a polymerizable comonomer, which provides a zwitterionic polymer having less than 100 mole percent zwitterionic moieties (e.g., when the polymerizable zwitterionic monomer and the polymerizable comonomer are present in equal proportions in the polymerization mixture, the product is a zwitterionic polymer having 50 mole percent zwitterionic moieties).
- polymerizable comonomer refers to a non-zwitterionic comonomer that is copolymerizable with a zwitterionic monomer.
- Representative polymerizable comonomers include acrylic acids, acrylates, methacrylic acids, methacrylates, and other comonomers include those that include hydrophilic moieties such as polyethylene oxides.
- the polymerizable comonomer described herein is not a polymerizable monomer that includes a zwitterionic moiety.
- zwitterionic polymers prepared from zwitterionic monomers have the formula:
- R 4 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R 5 and R 6 are independently selected from the group consisting of alkyl and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- L 4 is a linker that covalently couples the cationic center [N + (R 5 )(R 6 )] to the polymer backbone [—(CH 2 —CR 4 ) n —];
- L 5 is a linker that covalently couples the anionic center [A 2 ( ⁇ O)—O ⁇ ] to the cationic center;
- a 2 is C, S, SO, P, or PO;
- X ⁇ is a counter ion associated with the cationic center
- n is an integer from 5 to about 10,000.
- Representative monomers for making carboxybetaine polymers include carboxybetaine methacrylates, such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt; carboxybetaine acrylates; carboxybetaine acrylamides; carboxybetaine vinyl compounds; carboxybetaine epoxides; and other carboxybetaine compounds with hydroxyl, isocyanates, amino, or carboxylic groups.
- Representative monomers for making sulfobetaine polymers include sulfobetaine methacrylate (SBMA), sulfobetaine acrylates, sulfobetaine acrylamides, sulfobetaine vinyl compounds, sulfobetaine epoxides, and other sulfobetaine compounds with hydroxyl, isocyanates, amino, or carboxylic groups.
- SBMA sulfobetaine methacrylate
- SBMA sulfobetaine acrylates
- sulfobetaine acrylamides sulfobetaine vinyl compounds
- sulfobetaine epoxides sulfobetaine epoxides
- the representative polymerization methods include atom transfer radical polymerization (ATRP), reversible addition fragmentation chain transfer (RAFT) polymerization, and free radical polymerization.
- Any conventional radical initiators for polymerization may be used to practice the current invention.
- the representative initiators for normal thermal or photochemical free radical polymerization include benzoyl peroxide, 2,2′-azo-bis(2-methylproionitrile) and benzoin methyl ether.
- Representative initiators for ATRP include alkyl halides, such as bromoisobutyryl bromide (BIBB).
- Representative initiators for RAFT polymerization i.e., free radical initiators with chain reversible agency (CTA)
- CTA free radical initiators with chain reversible agency
- zwitterionic polymers can be prepared from N-oxide monomers, as described in WO 2019/006398, expressly incorporated herein by reference in its entirety, and shown below.
- the N-oxide monomer provides a polymer repeating unit that includes an N-oxide moiety that is pendant from the polymer backbone (i.e., forms a part of the polymer side chain).
- Representative polymers having N-oxide moieties that are pendant from the polymer backbone have the following formula:
- B is a polymer backbone
- L is a linker group that links the N-oxide moiety to the backbone
- representative groups include —(CH 2 ) x —, —(CH(CN)) x —, —C( ⁇ O)NH(CH 2 ) x —, —C( ⁇ O)O(CH 2 ) x —, —C( ⁇ O)OC( ⁇ O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 1 to 20;
- R 1 and R 2 are independently selected from the group consisting of hydrogen, C 1 -C 20 alkyl (including cyclic alkyl, e.g., C3-C7 cycloalkyl), and C 6 -C 12 aryl; and
- the N-oxide monomer provides a polymer repeating unit that includes an N-oxide moiety that is in the polymer backbone (i.e., forms a part of the polymer backbone).
- Representative polymers having N-oxide moieties in the polymer backbone have the following formula:
- R 1 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, cyano, C 1 -C 20 alkyl, and C 6 -C 12 aryl;
- R 2 and R 3 are independently selected from functional groups suitable for polymerization by addition, condensation or free radical polymerization;
- L 3 and L 4 are independently selected from —(CH 2 ) x —, —(CH(CN)) x —, —C( ⁇ O)NH(CH 2 ) x —, —C( ⁇ O)O(CH 2 ) x —, —C( ⁇ O)OC( ⁇ O)O(CH 2 ) x —, —(CH 2 ) x —O—(CH 2 ) x —, and —(CH 2 ) x —S—S—(CH 2 ) x —, where x at each occurrence is an integer independently selected from 0 to 20, preferably from 1 to 20, and n is an integer from about 10 to about 500.
- zwitterionic polymer also refers to a polymer having a substantially equal number of negative (anionic) charges and positive (cationic) charges that is prepared by copolymerizing a polymerizable negatively charged monomer and a polymerizable positively charged monomer, each present in substantially equal proportions in the polymerization mixture.
- the product of such a copolymerization is a zwitterionic polymer having 100 mole percent zwitterionic moieties, where each zwitterionic moiety is defined as a pair of repeating units: a repeating unit having a negative charge and a repeating unit having a positive charge.
- Such zwitterionic polymers are referred to as mixed charge copolymers.
- zwitterionic polymer also refers to a polymer prepared by copolymerizing a polymerizable negatively charged monomer, a polymerizable positively charged monomer, each present in substantially equal proportions in the polymerization mixture, and a polymerizable comonomer, which provides a zwitterionic polymer having less than 100 mole percent zwitterionic moieties (e.g., when the combination of polymerizable negatively charged monomer and polymerizable positively charged monomer and the polymerizable comonomer are present in equal proportions in the polymerization mixture (i.e., 50% combination of polymerizable negatively charged monomer and polymerizable positively charged monomer and 50% polymerizable comonomer), the product is a zwitterionic polymer having 50 mole percent zwitterionic moieties).
- R 7 and R 8 are independently selected from hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R 9 , R 10 , and R 11 are independently selected from alkyl and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- L 6 is a linker that covalently couples the cationic center [N + (R 9 )(R 10 )(R 11 )] to the polymer backbone;
- X ⁇ is the counter ion associated with the cationic center
- n is an integer from 5 to about 10,000;
- p is an integer from 5 to about 10,000.
- substantially electronically neutral means that the number of positively charged repeating units and the number of the negatively charged repeating units are substantially equal, and that there is a uniform distribution of mixed charged groups at the nanometer scale.
- the ratio of the number of the negatively charged repeating units or the repeating units having latent negatively charged groups to the number of the positively charged repeating units or repeating units having latent positively charged groups is from about 1:1.1 to about 1:0.5. In one embodiment, the ratio of the number of the negatively charged repeating units or the repeating units having latent negatively charged groups to the number of the positively charged repeating units or repeating units having latent positively charged groups is from about 1:1.1 to about 1:0.7. In one embodiment, the ratio of the number of the negatively charged repeating units or the repeating units having latent negatively charged groups to the number of the positively charged repeating units or repeating units having latent positively charged groups is from about 1:1.1 to about 1:0.9.
- the zwitterionic copolymers useful in the present invention comprise a plurality of positively charged repeating units having a positively charged pendant group.
- Representative positively charged pendant groups include a quaternary ammonium group, a primary amine group, a secondary amine group, a tertiary amine group, a quaternary phosphonium group, a tertiary phosphonium group, an amide group, a heteroaromatic nitrogen group, and a sulfonium group.
- the copolymers useful in the present invention comprise a plurality of negatively charged repeating units having a negatively charged pendant group.
- Representative negatively charged pendant groups include a sulfuric acid group, a carboxylic acid group, a phosphoric acid group, a nitric acid group, a phenol group, and a sulfonamide group.
- the copolymers useful in the present invention comprise the repeating units having latent negatively charged groups, wherein the latent negatively charged groups are selected from the group consisting of a sulfuric acid ester group, a carboxylic acid ester group, a phosphoric acid ester group, a sulfone group, a sulfide group, a disulfide group, an ortho ester group, an anhydride group, and a beta-ketosulfone group.
- the copolymers useful in the present invention comprise the repeating units having latent positively charged groups, wherein the latent positively charged groups are selected from the group consisting of an imide group and an oxyimino group.
- the latent negatively charged groups and latent positively charged groups in the copolymers useful in the present invention can be converted to charged groups upon exposure to an oxidant, a reductant, heat, light, an acid, a base, an enzyme, or electromagnetic field.
- Non-charged (latent) monomers are described in U.S. Pat. Nos. 8,268,301 and 8,349,966, each expressly incorporated herein by reference in its entirety, as well as herein.
- a second chemical polymeric network comprising a second zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- the first crosslinked zwitterionic polymer is a chemically crosslinked zwitterionic polymer
- the second crosslinked zwitterionic polymer is a chemically crosslinked zwitterionic polymer
- the term “chemical polymeric network” refers to a polymeric network that is prepared by a chemical method; specifically by polymerization.
- each of the first and second network is prepared by polymerization. More specifically, once the first chemical polymeric network is prepared, a second chemical polymeric network is prepared by polymerizing a suitable polymerizable monomer (or copolymerizing suitable comonomers) in the presence of the first polymeric network (e.g., polymerizing the suitable polymerizable monomer in a solution that includes first polymeric network).
- Chemical polymeric networks are distinguished from physical networks, which are prepared from polymers (or copolymers) by mechanical means and include interpolymer crosslinking, such as ionic, hydrogen bonding, and dipole-dipole crosslinking. Accordingly, double networks can be chemical-chemical networks, chemical-physical networks, or physical-physical networks. Physical, chemical, and chemical-physical double networks of zwitterionic hydrogels are described in Jiang et al., J. Phys. Chem. B 2008, 112: 5327-5332.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- a first polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties, wherein the first crosslinked zwitterionic polymer is not a poly(sulfobetaine);
- a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- the first crosslinked polymer is a zwitterionic polymer, a polysaccharide, or a collagen.
- Representative first crosslinked polymers include hyaluronic acids, alginates, or dextrans.
- the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa. In certain of these embodiments, the compressive fracture stress of greater than about 2, 3, 5, 8, 10, 12, or 15 MPa.
- the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa
- the double network hydrogel may also be characterized as having a tensile fracture stress greater than about 0.3 MPa (e.g., greater than about 0.5, 0.7, or 1.0 MPa), a tensile fracture strain greater than about 200% (e.g., greater than about 250% or 300%), or a Young's modulus greater than about 0.01 MPa (e.g., greater than about 0.1, 0.5, 1.0 MPa).
- the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- a second polymeric network comprising a crosslinked poly(sulfobetaine) having from about 50 to about 100 mole percent zwitterionic moieties.
- the first crosslinked zwitterionic polymer is a poly(carboxybetaine) (pCB), poly(sulfobetaine) (pSB), poly(sulfabetaine) (pSAB), poly(phosphobetaine) (pPB), poly(phosphorylcholine) (pPC), poly(choline phosphate) (pCP), poly(trimethylamine-N-oxide) (pTMAO), or a latent derivative thereof.
- pCB poly(carboxybetaine)
- pSB poly(sulfobetaine)
- pSAB poly(sulfabetaine)
- pPB poly(phosphobetaine)
- pPC poly(phosphorylcholine)
- pCP poly(choline phosphate)
- pTMAO poly(trimethylamine-N-oxide)
- the second crosslinked zwitterionic polymer is a poly(carboxybetaine) (pCB), poly(sulfobetaine) (pSB), poly(sulfabetaine) (pSAB), poly(phosphobetaine) (pPB), poly(phosphorylcholine) (pPC), poly(choline phosphate) (pCP), poly(trimethylamine-N-oxide) (pTMAO), or a latent derivative thereof.
- pCB poly(carboxybetaine)
- pSB poly(sulfobetaine)
- pSAB poly(sulfabetaine)
- pPB poly(phosphobetaine)
- pPC poly(phosphorylcholine)
- pCP poly(choline phosphate)
- pTMAO poly(trimethylamine-N-oxide)
- the first crosslinked zwitterionic polymer is a poly(carboxybetaine) (pCB) and the second crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB).
- the first crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB) and the second crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB).
- the first crosslinked zwitterionic polymer is a poly(phosphorylcholine) (pPC) and the second crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB).
- the first crosslinked polymer is a zwitterionic polymer crosslinked with a metal ion selected from Fe 3+ , Ca 2+ , Mg 2+ , Cu 2+ , and Zn 2+ .
- the zwitterionic double network hydrogels described herein have advantageous mechanical strength characterized as having one or more of a compressive fracture stress greater than about 0.9 MPa (e.g., greater than about 2, 3, 5, 8, 10, 12, or 15 MPa); a tensile fracture stress greater than about 0.3 MPa (e.g., greater than about 0.5, 0.7, or 1.0 MPa); a tensile fracture strain greater than about 200% (e.g., greater than about 250% or 300%); or a Young's modulus greater than about 0.01 MPa (e.g., greater than about 0.1, 0.5, or 1.0 MPa).
- a compressive fracture stress greater than about 0.9 MPa e.g., greater than about 2, 3, 5, 8, 10, 12, or 15 MPa
- a tensile fracture stress greater than about 0.3 MPa e.g., greater than about 0.5, 0.7, or 1.0 MPa
- a tensile fracture strain greater than about 200% (e.g., greater than about
- the zwitterionic double network hydrogels described herein have advantageous nonfouling properties characterized as having a fibrinogen binding level of less than about 20% (e.g., less than about 15% or less than about 10%) relative to that of tissue culture polystyrene (TCPS) tested via a fibrinogen binding assay (wherein the polymer surface is incubated at 37° C. for 90 minutes with a 1.0 mg/mL fibrinogen solution in 0.15 M phosphate buffered saline at pH 7.4).
- tissue culture polystyrene TCPS
- fibrinogen binding assay wherein the polymer surface is incubated at 37° C. for 90 minutes with a 1.0 mg/mL fibrinogen solution in 0.15 M phosphate buffered saline at pH 7.4
- the zwitterionic double network hydrogels described herein have water contents greater than about 50% (e.g., greater than about 70%, 80%, or 90%) and low or no swelling (i.e., a swelling ratio, V 2e /V 2 , less than 2, where V 2 is the volume of ZDN hydrogel in the as-prepared state and V 2e is the volume of ZDN hydrogel soaked in DI water or 0.15 M phosphate buffered saline at pH 7.4 until equilibrium is reached).
- the zwitterionic double network hydrogels have at least 50 mole percent zwitterionic moieties (e.g., 60, 70, 80, 90, 100 mole percent). Higher zwitterionic content is preferred for imparting nonfouling properties to the hydrogel as long as the advantageous mechanical properties are achieved.
- the first network is relatively heavily crosslinked compared to the second network, which is relatively lightly crosslinked.
- the zwitterionic double network hydrogels of the invention can be defined as containing 2-15 mass % first network (e.g., pCB) and 85-98 mass % second network (e.g., pSB), as shown in FIG. 4 (given as mass %).
- the zwitterionic double network (ZDN) hydrogels of the invention are designated by the polymerization conditions for each of the first and second hydrogel networks: monomer molality-crosslinker mol %-initiator mol % (mol % based on polymerizable zwitterionic monomer or comonomers).
- monomer molality-crosslinker mol %-initiator mol % mol % based on polymerizable zwitterionic monomer or comonomers.
- a representative designation is 1-4-0.1
- a representative designation is 4-0.1-0.01
- the representative double network is designated 1-4-0.1/4-0.1-0.01.
- the term “monomer molality” refers to moles of monomer per kilogram of solvent of the solution used to prepare the first and second polymer networks.
- the second network provides a locking effect and is the majority of the ZDN hydrogel based on mass (amount to about 85 to 95 mol % of the whole ZDN hydrogel).
- pCB/pSB ZDN hydrogels [1-3]-[2-50]-[0.1-1]/[2-6]-[0-0.5]-[0.01-1].
- pCB/pSB ZDN hydrogel 1-4-0.1/4-0.1-0.01.
- the first network has a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-10]-[1-50]-[0.1-1]. In certain of these embodiments, the first network has a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-2]-[2-4]-0.1.
- the first network is a poly(carboxybetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-2]-[2-4]-[0.1].
- the second network is a poly(sulfobetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [2-6]-[0-0.5]-[0.01-1].
- the first network is a poly(carboxybetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-3]-[2-50]-[0.1-1]
- the second network is a poly(sulfobetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [2-6]-[0-0.5]-[0.01-1].
- the zwitterionic double network hydrogels described herein can be obtained by a two-step process in which the first polymeric network is formed (e.g., by polymerization of zwitterionic monomers, crosslinking agents, and initiators, as necessary; copolymerization of zwitterionic and non-zwitterionic comonomers, crosslinking agents, and initiators, as necessary; or physical crosslinking of zwitterionic polymers or zwitterionic copolymers) and then soaked to equilibrium in a solution comprising precursors of the second polymeric network (e.g., zwitterionic monomers, crosslinking agents, and initiators, as necessary; zwitterionic and non-zwitterionic comonomers, crosslinking agents, and initiators, as necessary; or zwitterionic polymers or zwitterionic copolymers, and physical crosslinking agents), and the resulting first polymer network and the precursors of the second polymeric network are subject to polymerization
- the invention provides articles of manufacture comprising, in whole or in part, a zwitterionic double network hydrogel described herein.
- the article is a consumer product.
- Representative consumer products include wound dressings or wound care devices, skin sealants, dermatology devices (skin repair devices, bandages), cosmetic devices or formulations (topical creams, topical masks, injectable or implantable gels or other formulation for aesthetic, reconstructive or rejuvenation purposes), contact lens, OB/Gyn devices (implantable or topical birth control devices, vaginal slings), intra-ocular lens, aesthetic implants (breast implants, nasal implants, cheek implants), hormone control implants (blood sugar sensors, insulin pumps), urology devices (catheters, artificial urethrae).
- the article is a marine product.
- Representative marine products include, in whole or in part, marine vessel hulls, marine structures, bridges, propellers, heat exchangers, periscopes, sensors, fish nets, cables, tubes/pipes, containers, membranes, and oil booms.
- the invention provides a microgel, comprising a zwitterionic double network hydrogel described herein.
- the substrate is a consumer product.
- Representative consumer products include those listed above.
- ZDN hydrogels were synthesized by a two-step sequential free-radical polymerization.
- the first step the first network poly ⁇ 3-[3-(acrylamidopropyl)dimethylammonio]propionate ⁇ (pCB) hydrogels were synthesized by photopolymerization using 1 m (molality) of CB, 4 mol % of crosslinker N,N-methylenebis(acrylamide) (MBAA), and 0.1 mol % of initiator 2-hydroxy-2-methylpropiophenone (1173) (both were relative to the CB monomer) in a transparent sheet molds or tubular rod molds under an ultraviolet (UV) irradiation with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket.
- UV ultraviolet
- the polymerization condition of the first network hydrogel is denoted as 1-4-0.1 (CB molality-crosslinker mol %-initiator mol %).
- the as-prepared pCB hydrogel was immersed into the precursor solution of second network containing 4 m of [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (SB), 0.1 mol % of MBAA and 0.01 mol % of initiator 1173 (both were relative to the SB monomer) for 24 h.
- the polymerization condition of the second network hydrogel is denoted as 4-0.1-0.01 (SB molality-crosslinker mol %-initiator mol %).
- the polymerization condition of ZDN hydrogel is denoted as 1-4-0.1/4-0.1-0.01.
- the fully swollen first network hydrogel containing the precursor solution of second network is further polymerized by UV irradiation with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket.
- the as-prepared pCB/pSB ZDN hydrogels were immersed in an aqueous solution for 1 day until they reached swelling equilibrium.
- first network 1-2-0.1 and 2-4-0.1
- second network 4-0-0.01, 4-0.01-0.01, 4-0.2-0.01, 4-0.5-0.01, 2-0.1-0.01 and 6-0.1-0.01
- ZDN hydrogels were prepared according to the methods described above. In addition to 1-4-0.1/4-0.1-0.01, different combination of first network (1-2-0.1 and 2-4-0.1) and second network (4-0-0.01, 4-0.01-0.01, 4-0.2-0.01, 4-0.5-0.01, 2-0.1-0.01 and 6-0.1-0.01) were used for the synthesis of ZDN hydrogels.
- the equilibrium swelling ratio (ESR) of equilibrated ZDN hydrogels to their as-prepared state was evaluated via a dimension measurement method.
- the as-prepared ZDN hydrogel disks were cut by a biopsy punch (5 or 10 mm in diameter).
- the diameters (r1) and heights (h1) of as-prepared ZDN hydrogel disks were measured and then soaked in deionized water at 37° C. for 2 days for completely swelling.
- the diameters (r2) and heights (h2) of their corresponding equilibrated state were measured.
- the ESRs were calculated as below. Each measurement was performed in triplicate.
- the equilibrium water content (EWC) of ZDN hydrogels was measured through a gravimetric method.
- ZDN hydrogel disks (10 mm in diameter and 1 mm in thickness) were allowed to swell in deionized water until reaching equilibrium at 37° C.
- the equilibrated samples were taken out and their wet mass (M w ) were measured after the removal of excess water on the surface by rolling them on filter papers.
- the samples were then snap-frozen in liquid nitrogen and lyophilized for 2 days until a complete dryness and their dry mass (M d ) were measured.
- M d wet mass
- the first network hydrogel were allowed to swell in deionized water until reaching equilibrium at 37° C. Their dry mass (MO were acquired after snap-frozen in liquid nitrogen and lyophilized for 2 days. The mass percentages (MS) of first network hydrogel were calculated as below. Each measurement was performed in triplicate.
- Compressive and tensile tests were performed by a tensile-compressive mechanical tester (Instron 5543A, Instron Corp., Norwood, Mass.) with a 1 kN load cell to record the mechanical properties of the equilibrated pCB/pSB ZDN hydrogel samples.
- crosshead speed was set at 10 mm min ⁇ 1 .
- the equilibrium sheet samples were cut into rectangular pieces with dimensions of 20 mm ⁇ 2 mm ⁇ 0.50 mm.
- the crosshead speed was set at 1 mm min ⁇ 1 .
- the equilibrium tubular rod samples were cut with diameter and height of 5 and 3.5 to 4 mm, respectively. Average data were acquired by testing five specimens for each sample.
- the equilibrated pCB/pSB ZDN hydrogel had compressive fracture stress more than 15 MPa and stayed intact with 99% of compressive strain measured by compression test.
- the equilibrated pCB/pSB ZDN hydrogel had tensile fracture stress about 1 MPa and tensile fracture strain more than 300% measured by tensile test.
- a fibrinogen adsorption test used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- ZDN zwitterionic double network
- Fibrinogen was chosen as the test protein to examine the nonfouling property of the ZDN samples.
- Fg adhesion To measure Fg adhesion, the equilibrated pCB/pSB ZDN hydrogel samples were first incubated with 1 mL of 1 mg mL ⁇ 1 Fg in 0.15 M phosphate buffered saline (PBS) buffer at pH 7.4 for 1.5 hours, followed by 5 washes with pure PBS buffer. Samples were then transferred to new wells and incubated with 1 mL of horseradish peroxidase (HRP) conjugated anti-fibrinogen (1 ⁇ g mL ⁇ 1 ) in PBS buffer for 1.5 hours.
- HRP horseradish peroxidase
- a serum adsorption test by micro-BCA assay used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- ZDN zwitterionic double network
- a platelet attachment analysis by lactate dehydrogenase assay used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- ZDN zwitterionic double network
- Platelets used for adhesion analysis were freshly collected from the blood of Sprague Dawley (SD) rats. Fresh blood collected was then immediately centrifuged at 200 g for 10 min to get platelet rich plasma (PRP). The residue was further centrifuged at 2000 g for 20 min to obtain platelet poor plasma (PPP). PRP and PPP were gently remixed and the final platelet density was adjusted to 2 ⁇ 108 mL ⁇ 1 .
- Pre-equilibrated hydrogel disks in PBS (5 mm in diameter and 1 mm in thickness) were placed in 24-well TCPS with one disk per well, immersed with 400 ⁇ L of final platelet solution and incubated at 37° C. for 3 h.
- the disks were rinsed with 1 mL of PBS five times and then transferred into new wells.
- the number of adhered platelets was determined by the lactate dehydrogenase (LDH) assay.
- LDH assay the rinsed samples were soaked in 24-well TCPS with 300 ⁇ L PBS and 10 ⁇ L 10 ⁇ lysis buffer and incubated at 37° C., 5% carbon dioxide for 45 minutes. 50 ⁇ L reaction mixtures were then added into each well and incubated at room temperature for 30 minutes in the dark. To stop the reaction, 50 ⁇ L stop solution was added to each well and mixed by gentle pipetting.
- LDH lactate dehydrogenase
- a cell attachment assay used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- Rat pancreatic ⁇ cells RIN-m5F and murine DC 2.4 dendritic cells were selected for the cell adhesion assay of the hydrogels.
- PBS pre-equilibrated and UV sterilized hydrogels disks (5 mm in diameter and 1 mm in thickness) were placed individually into the wells of a 96-well plate.
- RIN-m5F or DC 2.4 cells suspended in corresponding culture medium were seeded onto the hydrogels at a density of 1 ⁇ 105 cells/mL or 5 ⁇ 104 cells/mL, respectively, and allowed to grow for 24 h at 37° C. in a humidified atmosphere with 5% carbon dioxide. The medium was then removed and the hydrogels were gently washed with PBS and re-immersed with PBS.
- pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01) were sterilized via a standard autoclaving method.
- As-prepared pCB/pSB ZDN hydrogels were soaked in water or PBS until equilibrium and then sterilized at 121° C. for 30 min together with corresponding soaking solutions. The sterilized hydrogels were then cooled to room temperature for further use or test. Hydrogels experienced one, two, or three rounds of such heating-cooling autoclaving sterilization process were named as ZDN-R1, ZDN-R2 and ZDN-R3, respectively. The subsequent mechanical property, protein adhesion and cell adhesion tests of autoclaved ZDN hydrogels all followed the protocols described as above.
- mice Six to eight-week-old male C57BL/6 mice were purchased from Charles River Labs. All the animal experiments were operated according to the federal guidelines and were approved by the University of Washington Animal Care and Use Committee. Subcutaneous implantation experiments were carried out to evaluate the foreign-body reaction and fibrous capsule formation of pCB/pSB ZDN hydrogels.
- pHEMA hydrogels with the same shape and dimension were set as positive control and were sterilized with UV for 30 min before surgery. The animal surgery was performed under anesthesia and aseptic conditions.
- each mouse was subcutaneously implanted with two ZDN or two pHEMA hydrogels symmetrically on the back with one sample on each side.
- Mice were anesthetized using 3% isoflurane and shaved. The area where the incision would be made was sterilized using iodine and 70% ethanol. A longitudinal incision (no longer than 1 cm) was made on the central dorsal surface using surgical scissors to provide access to the subcutaneous space. Subcutaneous pockets on either side of the incision were created with a blunt forceps for the implantation of the hydrogel samples. After implantation, the incisions were closed using wound nylon sutures and analgesic (Meloxicam) was administered. Twelve replicates of each type of hydrogel were implanted into six different mice to provide statistical significance in the histological studies. Mice were monitored until recovery from anesthesia and housed for 1 week, 4 weeks, 12 weeks, or 24 weeks before retrieving samples.
- ZDN zwitterionic double network
- ZDN microgels were produced using a stainless-steel piston and cylinder apparatus, where bulk hydrogels of the invention, pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01), were extruded through progressively finer micronic steel meshes (TWP; 500 ⁇ m down to 25 ⁇ m pores). Microgels were passed through the final mesh size five times for size homogeneity.
- Zoospores were obtained from mature plants of U. linza by the standard method. A suspension of zoospores (15 ml; 7.5 ⁇ 10 5 spores ml ⁇ 1 ) was added to individual compartments of quadriPERM dishes containing the samples. After 45 minutes in darkness at about 20° C., the slides were observed under the microscope to determine whether there was any settlement on the surfaces. The samples were then washed by moving back and forth under seawater to remove unsettled (i.e., swimming) spores. Care was taken that the samples did not move through the air water interface. The samples were again viewed through the microscope and counts of spores were made on the wet samples.
- the density of zoospores attached to the surfaces was counted on each of 3 replicate slides using an image analysis system attached to a fluorescence microscope. Spores were visualised by autofluorescence of chlorophyll. Counts were made for 30 fields of view (each 0.15 mm 2 ) on each slide.
- N. incerta diatom attachment and adhesion tests used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- the single-pot procedure was conducted by simply mixing zwitterionic pCB polymers, Ca 2+ ions, SB monomer, MBAA crosslinker, 1173 photo-reactive initiator and DI water in single container.
- the pCB interacted with Ca 2+ ions (ionic bonding) and formed the first network, followed by photo-initiating polymerization of SB via exposing to UV with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket.
- the as-prepared ZDN hydrogel was immersed in DI water and the swelling ratio V 2e /V 2 , is less than 2, where V 2 is the volume of ZDN hydrogel in the as-prepared state and V ee is the volume of ZDN hydrogel soaked in DI water until equilibrium.
- the hybrid (physically and chemically) crosslinked pCB/pSB ZDN hydrogel was successfully formed via single-pot method.
- Ca 2+ , Mg 2+ , Cu 2+ , and Fe 3+ were used respectively to interact with pCB to successfully form the first network via the ionic bonding.
- ZDN hydrogels of the invention preparation and characteristics of representative zwitterionic double network (ZDN) hydrogels of the invention, pTMAO/pSB ZDN hydrogels, are described.
- pTMAO/pSB ZDN hydrogels were synthesized by a two-step sequential free-radical polymerization.
- the first network poly(trimethylamine-N-oxide) (pTMAO) hydrogels were synthesized by photo polymerization using 1 m of TMAO, 4 mol % of cross-linker N,N-methylenebis(acrylamide) (MBAA), and 0.1 mol % of initiator 2-hydroxy-2-methylpropiophenone (1173) (both were relative to the TMAO monomer) in a transparent sheet molds or tubular rod molds under an ultraviolet (UV) irradiation with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket.
- UV ultraviolet
- the as-prepared pTMAO hydrogel was immersed into the precursor solution of second network containing 4 m of [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (SB), 0.1 mol % of MBAA and 0.01 mol % of initiator 1173 (both were relative to the SB monomer) for 2 days.
- SB [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide
- MBAA 0.1 mol % of MBAA
- initiator 1173 both were relative to the SB monomer
- the as-prepared pTMAO/pSB ZDN hydrogels were immersed in an aqueous solution for 1 day until they reached swelling equilibrium.
- the equilibrated pTMAO/pSB ZDN hydrogel had low swelling behavior in DI water with only 7% volume increase compared to that of the pTMAO/pSB ZDN hydrogel in the as-prepared state.
- Compressive and tensile tests were performed by a tensile-compressive mechanical tester (Instron 5543A, Instron Corp., Norwood, Mass.) with a 10 kN load cell to record the mechanical properties of the equilibrated pTMAO/pSB ZDN hydrogel samples.
- crosshead speed was set at 10 mm min ⁇ 1 .
- the equilibrium sheet samples were cut into rectangular pieces with dimensions of 20 mm ⁇ 2 mm ⁇ 0.50 mm.
- the crosshead speed was set at 1 mm min ⁇ 1 .
- the equilibrium tubular rod samples were cut with diameter and height of 5 and 3.5 to 4 mm respectively. Average data were acquired by testing five specimens for each sample.
- the equilibrated pTMAO/pSB ZDN hydrogel had compressive fracture stress more than 10 MPa and stayed intact with 95% of compressive strain measured by compression test.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Wood Science & Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials For Medical Uses (AREA)
- Polymerisation Methods In General (AREA)
- Graft Or Block Polymers (AREA)
- Eyeglasses (AREA)
- Dental Preparations (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
- This application claims the benefit of U.S. Application No. 62/718,759, filed Aug. 14, 2018, and U.S. Application No. 62/818,574, filed Mar. 14, 2019, each expressly incorporated herein by reference in its entirety.
- This invention was made with government support under Grant Nos. N00014-16-1-3084 and N00014-19-1-2063 awarded by the Office of Naval Research. The government has certain rights in the invention.
- Hydrogels with three-dimensional crosslinked networks and high capacity of water are of interest because of their potential in biomedical applications, such as biosensor devices, tissue implants, and contact lenses or marine applications, such as ship hulls, marine structures, marine sensors and fishing nets. Hydrogels made from zwitterionic materials are further of high interest for their superhydrophilicity and excellent non-fouling properties that prevent complications and device failure by resisting nonspecific biofouling from proteins, cells, and micro-organisms. However, due to their polyelectrolyte nature and high glass transition temperature (Tg), improvement in mechanical properties of zwitterionic hydrogels is desirable.
- Despite the advantageous nonfouling properties of zwitterionic hydrogels, a need exists for zwitterionic hydrogels having improved mechanical properties. The present invention seeks to fulfill this need and provides further related advantages.
- The present invention provides zwitterionic double network hydrogels, methods for making zwitterionic double network hydrogels, methods for using zwitterionic double network hydrogels, and articles made from and coated with zwitterionic double network hydrogels.
- In one aspect, the invention provides zwitterionic double network hydrogels.
- In one embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties; and
- (b) a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties,
- wherein the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- In another embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first chemical polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties; and
- (b) a second chemical polymeric network comprising a second zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- In a further embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties, wherein the first crosslinked zwitterionic polymer is not a poly(sulfobetaine); and
- (b) a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- In another embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked polymer, wherein the first polymeric network is a hydrogel; and
- (b) a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- In a further embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked polymer, wherein the first polymeric network is a hydrogel; and
- (b) a second polymeric network comprising a crosslinked poly(sulfobetaine) having from about 50 to about 100 mole percent zwitterionic moieties, wherein the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- In another aspect, the invention provides methods for making the zwitterionic double network hydrogels. In one embodiment, the method is a two-step method. In another embodiment, the method is a one-step (single-pot) process.
- In a further aspect of the invention, articles of manufacture made from or that include the zwitterionic double network hydrogel are provided.
- The foregoing aspects and many of the attendant advantages of this invention will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings.
-
FIG. 1 is a schematic illustration of the preparation of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel. -
FIG. 2A compare the swelling behaviors of the as-prepared pCB/pSB ZDN hydrogel and the swollen (fully equilibrated) ZDN hydrogel after soaking in DI water. Hydrogels were made according to the composition of 1-4-0.1/4-0.1-0.01. -
FIG. 2B compares equilibrium swelling ratios (%) and equilibrium water content (%) of pCB/pSB ZDN hydrogels with three (3) zwitterionic single network [ZSN1 (1-2-0.1, 1-4-0.1, and 2-4-0.1)] and seven (7) zwitterionic single network [ZSN2 (4-0-0.01, 4-0.01-0.01, 4-0.1-0.01, 4-0.2-0.01, 4-0.5-0.01, 2-0.1-0.01, and 6-0.1-0.01)] component ratios. -
FIGS. 3A-3C compare compressive fracture stress (3A), compressive fracture strain (3B), and compressive modulus (3C) of representative pCB/pSB ZDN hydrogels with three (3) different pCB ZSN1 (1-2-0.1, 1-4-0.1, and 2-4-0.1) and seven (7) pSB ZSN2 (2-0.1-0.01, 4-0-0.01, 4-0.01-0.01, 4-0.1-0.01, 4-0.2-0.01, 4-0.5-0.01, and 6-0.1-0.01) component ratios. -
FIG. 4 compares the mass percentage of representative pCB/pSB ZDN hydrogels with three (3) different pCB ZSN1 (1-2-0.1, 1-4-0.1, and 2-4-0.1) and seven (7) pSB ZSN2 (2-0.1-0.01, 4-0-0.01, 4-0.01-0.01, 4-0.1-0.01, 4-0.2-0.01, 4-0.5-0.01, and 6-0.1-0.01) component ratios. -
FIGS. 5A and 5B compare representative uniaxial compressive curves (5A) and compressive modulus, fracture stress, and fracture strain (5B) of representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01), a pCB single network (SN) hydrogel (1-4-0.1), and a pSB single network (SN) hydrogel (4-0.1-0.01). -
FIGS. 6A and 6B compare representative tensile curves (6A) and tensile modulus, fracture stress, and fracture strain (6B) of representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01), a pCB single network hydrogel (SN, 1-4-0.1) and a pSB single network hydrogel (SN, 4-0.1-0.01). -
FIGS. 7A-7F compare relative nonfouling (protein and cell adhesion) of representative zwitterionic double network (pCB/pSB ZDN) hydrogel (1-4-0.1/4-0.1-0.01) surfaces: human fibrinogen (7A), proteins in undiluted human serum (7B), rat platelets (7C), RIN-m5F cells (7D), and DC 2.4 cells (7E). All the data were normalized with respect to tissue culture polystyrene (TCPS). Optical images of RIN-m5F cells and DC 2.4 cells respectively adhered on TCPS and pCB/pSB ZDN hydrogel surfaces are compared inFIG. 7F . The magnification of all images was 200×. -
FIGS. 8A-8D compare relative nonfouling (protein and cell adhesion) of representative zwitterionic double network (pCB/pSB ZDN) hydrogel (1-4-0.1/4-0.1-0.01) surfaces after three rounds of autoclaving (ZDN-R1, ZDN-R2 and ZDN-R3): proteins in undiluted human serum (8A), rat platelets (8B), RIN-m5F cells (8C), and DC 2.4 cells (8D). All the data were normalized with respect to TCPS. -
FIGS. 9A-9C compare hemotoxylin and eosin (H&E) staining for skin tissues with a representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01) after one week of implantation compared to pHEMA and Control (9A); Masson's trichrome staining for skin tissues with a representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01) after implantation for 1, 4, and 12 weeks compared to pHEMA; images of implanted mice and retrieved representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01) and Masson's trichrome staining for skin tissues with pCB/pSB ZDN hydrogels after implantation for 24 weeks. Skin tissues of mice without implants were set as control. The magnification of all tissue staining images was 100×. -
FIG. 10 compares degradation (weight remaining) and mechanical properties (compressive modulus remaining, compressive stress remaining, compressive strain remaining) of representative pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01) after implantation for 12 weeks. -
FIGS. 11A-11C compare compressive stress curves (11A), compressive modulus, fracture stress, and fracture strain (11B), and equilibrium swelling ratios and equilibrium water contents for representative ZDN hydrogels of the invention: pCB/pSB, pCB/pCB, pSB/pCB, pSB/pSB ZDN hydrogels. pCB/pSB and pSB/pSB ZDN hydrogels were made according to the composition of 1-4-0.1/4-0.1-0.01 and pCB/pCB and pSB/pCB ZDN hydrogels were made according to the composition of 1-4-0.1/4-0.2-0.01. -
FIGS. 12A-12C compare compression tests of representative ZDN hydrogels: pSB/pSB (12A), pCB/CB (12B), and pSB/CB (12C). In each, the first networks of ZDN hydrogels were made according to the composition of 1-4-0.1. The second networks of the ZDN hydrogels were made according to the seven (7) different compositions as indicated in the figure. -
FIGS. 13A-13C compare compression tests of representative pCB/CB ZDN hydrogels: the first network of hydrogels were made according to the composition of 1-2-0.1 (13A), 1-4-0.1 (13B), and 2-4-0.1 (13C). The second network of the pCB/pCB ZDN hydrogels were made according to the seven (7) different compositions as indicated in the figure. -
FIGS. 14A-14C compare attachment and adhesion tests of diatoms on a representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), glass, and PDMS: density (number/mm2) of attached diatoms after 2 hours followed by washing (14A); removal (%) of diatoms due to exposure to a shear stress of 26 Pa (14B); and density (number/mm2) of diatoms remaining after washing and exposure to a shear stress of 26 Pa (14C). Each point is the mean from 90 counts on 3 replicate slides. Bars show 95% confidence limits derived from arc-sine transformed data. -
FIGS. 15A-15C compare attachment and adhesion tests of Ulva spores on a representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), glass, and PDMS: density (number/mm2) of attached spores after 45 minutes settlement followed by washing (15A); removal (%) of spores due to washing and exposure to a shear stress of 52 Pa (15B); and density (number/mm2) of spores remaining after washing and exposure to a shear stress of 52 Pa (15C). Each point is the mean from 90 counts on 3 replicate slides. Bars show 95% confidence limits derived from arc-sine transformed data. -
FIG. 16 compares compressive stress (MPa) and compressive strain (%) for a representative pTMAO/pSB ZDN hydrogel. The first network was made according to the composition 1-4-0.1 and the second network was made according the composition 4-0.1-0.01. - The present invention provides zwitterionic double network hydrogels, methods for making zwitterionic double network hydrogels, methods for using zwitterionic double network hydrogels, and articles made from and coated with zwitterionic double network hydrogels.
- Zwitterionic Double Network Hydrogels
- In one aspect, the invention provides zwitterionic double network hydrogels.
- In one embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties; and
- (b) a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties,
- wherein the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- As used herein, the term “crosslinked” refers to both chemically crosslinked physically crosslinked polymers, unless otherwise stated.
- In this embodiment, the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa. In certain of these embodiments, the compressive fracture stress of greater than about 2, 3, 5, 8, 10, 12, or 15 MPa.
- It will be appreciated that although the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa, the double network hydrogel may also be characterized as having a tensile fracture stress greater than about 0.3 MPa (e.g., greater than about 0.5, 0.7, or 1.0 MPa), a tensile fracture strain greater than about 200% (e.g., greater than about 250% or 300%), or a Young's modulus greater than about 0.01 MPa (e.g., greater than about 0.1, 0.5, 1.0 MPa).
- As used herein, the term “zwitterionic polymer” refers to a polymer prepared by polymerizing a polymerizable zwitterionic monomer, which provides a zwitterionic polymer having 100 mole percent zwitterionic moieties (i.e., each repeating unit of the zwitterionic polymer is a zwitterionic moiety); or refers to a polymer prepared by copolymerizing a polymerizable zwitterionic monomer and a polymerizable comonomer, which provides a zwitterionic polymer having less than 100 mole percent zwitterionic moieties (e.g., when the polymerizable zwitterionic monomer and the polymerizable comonomer are present in equal proportions in the polymerization mixture, the product is a zwitterionic polymer having 50 mole percent zwitterionic moieties).
- As used herein the term “polymerizable comonomer” refers to a non-zwitterionic comonomer that is copolymerizable with a zwitterionic monomer. Representative polymerizable comonomers include acrylic acids, acrylates, methacrylic acids, methacrylates, and other comonomers include those that include hydrophilic moieties such as polyethylene oxides. The polymerizable comonomer described herein is not a polymerizable monomer that includes a zwitterionic moiety.
- Representative polymerizable zwitterionic monomers and zwitterionic polymers prepared from zwitterionic monomers are described in U.S. Pat. Nos. 7,879,444 and 8,835,671, each expressly incorporated herein by reference in its entirety, as well as herein.
- Representative zwitterionic polymers prepared from zwitterionic monomers have the formula:
- wherein
- R4 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R5 and R6 are independently selected from the group consisting of alkyl and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- L4 is a linker that covalently couples the cationic center [N+(R5)(R6)] to the polymer backbone [—(CH2—CR4)n—];
- L5 is a linker that covalently couples the anionic center [A2(═O)—O−] to the cationic center;
- A2 is C, S, SO, P, or PO;
- M+ is a counterion associated with the (A2=O)O− anionic center;
- X− is a counter ion associated with the cationic center;
- n is an integer from 5 to about 10,000.
- Representative monomers for making carboxybetaine polymers (e.g., A2=C in the formula above) useful in the invention include carboxybetaine methacrylates, such as 2-carboxy-N,N-dimethyl-N-(2′-methacryloyloxyethyl) ethanaminium inner salt; carboxybetaine acrylates; carboxybetaine acrylamides; carboxybetaine vinyl compounds; carboxybetaine epoxides; and other carboxybetaine compounds with hydroxyl, isocyanates, amino, or carboxylic groups.
- Representative monomers for making sulfobetaine polymers (e.g., A2=SO in the formula above) useful in the invention include sulfobetaine methacrylate (SBMA), sulfobetaine acrylates, sulfobetaine acrylamides, sulfobetaine vinyl compounds, sulfobetaine epoxides, and other sulfobetaine compounds with hydroxyl, isocyanates, amino, or carboxylic groups.
- The representative polymerization methods include atom transfer radical polymerization (ATRP), reversible addition fragmentation chain transfer (RAFT) polymerization, and free radical polymerization. Any conventional radical initiators for polymerization may be used to practice the current invention. The representative initiators for normal thermal or photochemical free radical polymerization include benzoyl peroxide, 2,2′-azo-bis(2-methylproionitrile) and benzoin methyl ether. Representative initiators for ATRP include alkyl halides, such as bromoisobutyryl bromide (BIBB). Representative initiators for RAFT polymerization (i.e., free radical initiators with chain reversible agency (CTA)) include thiocarbonylthio compounds.
- Other zwitterionic polymers can be prepared from N-oxide monomers, as described in WO 2019/006398, expressly incorporated herein by reference in its entirety, and shown below.
- In certain embodiments, the N-oxide monomer provides a polymer repeating unit that includes an N-oxide moiety that is pendant from the polymer backbone (i.e., forms a part of the polymer side chain). Representative polymers having N-oxide moieties that are pendant from the polymer backbone have the following formula:
- wherein
- * indicates the point of attachment of the repeating unit to other repeating units in the polymer or copolymer;
- B is a polymer backbone;
- L is a linker group that links the N-oxide moiety to the backbone, representative groups include —(CH2)x—, —(CH(CN))x—, —C(═O)NH(CH2)x—, —C(═O)O(CH2)x—, —C(═O)OC(═O)O(CH2)x—, —(CH2)x—O—(CH2)x—, and —(CH2)x—S—S—(CH2)x—, where x at each occurrence is an integer independently selected from 1 to 20;
- R1 and R2 are independently selected from the group consisting of hydrogen, C1-C20 alkyl (including cyclic alkyl, e.g., C3-C7 cycloalkyl), and C6-C12 aryl; and
- n is an integer from about 10 to about 500.
- In other embodiments, the N-oxide monomer provides a polymer repeating unit that includes an N-oxide moiety that is in the polymer backbone (i.e., forms a part of the polymer backbone). Representative polymers having N-oxide moieties in the polymer backbone have the following formula:
- wherein
- R1 is selected from the group consisting of hydrogen, fluorine, trifluoromethyl, cyano, C1-C20 alkyl, and C6-C12 aryl;
- R2 and R3 are independently selected from functional groups suitable for polymerization by addition, condensation or free radical polymerization; and
- L3 and L4 are independently selected from —(CH2)x—, —(CH(CN))x—, —C(═O)NH(CH2)x—, —C(═O)O(CH2)x—, —C(═O)OC(═O)O(CH2)x—, —(CH2)x—O—(CH2)x—, and —(CH2)x—S—S—(CH2)x—, where x at each occurrence is an integer independently selected from 0 to 20, preferably from 1 to 20, and n is an integer from about 10 to about 500.
- The term “zwitterionic polymer” also refers to a polymer having a substantially equal number of negative (anionic) charges and positive (cationic) charges that is prepared by copolymerizing a polymerizable negatively charged monomer and a polymerizable positively charged monomer, each present in substantially equal proportions in the polymerization mixture. The product of such a copolymerization is a zwitterionic polymer having 100 mole percent zwitterionic moieties, where each zwitterionic moiety is defined as a pair of repeating units: a repeating unit having a negative charge and a repeating unit having a positive charge. Such zwitterionic polymers are referred to as mixed charge copolymers. The term “zwitterionic polymer” also refers to a polymer prepared by copolymerizing a polymerizable negatively charged monomer, a polymerizable positively charged monomer, each present in substantially equal proportions in the polymerization mixture, and a polymerizable comonomer, which provides a zwitterionic polymer having less than 100 mole percent zwitterionic moieties (e.g., when the combination of polymerizable negatively charged monomer and polymerizable positively charged monomer and the polymerizable comonomer are present in equal proportions in the polymerization mixture (i.e., 50% combination of polymerizable negatively charged monomer and polymerizable positively charged monomer and 50% polymerizable comonomer), the product is a zwitterionic polymer having 50 mole percent zwitterionic moieties).
- Representative polymerizable negatively charged monomers and polymerizable positively charged monomers and zwitterionic copolymers prepared from these monomers are described in U.S. Pat. Nos. 8,835,671 and 9,045,576, each expressly incorporated herein by reference in its entirety, as well as herein.
- Representative zwitterionic polymers prepared from polymerizable negatively charged monomers and polymerizable positively charged monomers have the formula:
- wherein
- R7 and R8 are independently selected from hydrogen, fluorine, trifluoromethyl, C1-C6 alkyl, and C6-C12 aryl groups;
- R9, R10, and R11 are independently selected from alkyl and aryl, or taken together with the nitrogen to which they are attached form a cationic center;
- A3(═O)—OM) is an anionic center, wherein A3 is C, S, SO, P, or PO, and M is a metal or organic counterion;
- L6 is a linker that covalently couples the cationic center [N+(R9)(R10)(R11)] to the polymer backbone;
- L7 is a linker that covalently couples the anionic center [A(═O)—OM] to the polymer backbone;
- X− is the counter ion associated with the cationic center;
- n is an integer from 5 to about 10,000; and
- p is an integer from 5 to about 10,000.
- In one embodiment, the zwitterionic copolymer useful in the invention includes (a) a plurality of negatively charged repeating units, or a plurality of latent negatively charged repeating units; and (b) a plurality of positively charged repeating units or a plurality of positively charged repeating units, wherein the copolymer is substantially electronically neutral.
- As used herein, the term “substantially electronically neutral” means that the number of positively charged repeating units and the number of the negatively charged repeating units are substantially equal, and that there is a uniform distribution of mixed charged groups at the nanometer scale.
- In general, the ratio of the number of the negatively charged repeating units or the repeating units having latent negatively charged groups to the number of the positively charged repeating units or repeating units having latent positively charged groups is from about 1:1.1 to about 1:0.5. In one embodiment, the ratio of the number of the negatively charged repeating units or the repeating units having latent negatively charged groups to the number of the positively charged repeating units or repeating units having latent positively charged groups is from about 1:1.1 to about 1:0.7. In one embodiment, the ratio of the number of the negatively charged repeating units or the repeating units having latent negatively charged groups to the number of the positively charged repeating units or repeating units having latent positively charged groups is from about 1:1.1 to about 1:0.9.
- In certain embodiments, the zwitterionic copolymers useful in the present invention comprise a plurality of positively charged repeating units having a positively charged pendant group. Representative positively charged pendant groups include a quaternary ammonium group, a primary amine group, a secondary amine group, a tertiary amine group, a quaternary phosphonium group, a tertiary phosphonium group, an amide group, a heteroaromatic nitrogen group, and a sulfonium group. In certain embodiments, the copolymers useful in the present invention comprise a plurality of negatively charged repeating units having a negatively charged pendant group. Representative negatively charged pendant groups include a sulfuric acid group, a carboxylic acid group, a phosphoric acid group, a nitric acid group, a phenol group, and a sulfonamide group.
- In certain embodiments, the copolymers useful in the present invention comprise the repeating units having latent negatively charged groups, wherein the latent negatively charged groups are selected from the group consisting of a sulfuric acid ester group, a carboxylic acid ester group, a phosphoric acid ester group, a sulfone group, a sulfide group, a disulfide group, an ortho ester group, an anhydride group, and a beta-ketosulfone group. In certain embodiments, the copolymers useful in the present invention comprise the repeating units having latent positively charged groups, wherein the latent positively charged groups are selected from the group consisting of an imide group and an oxyimino group.
- The latent negatively charged groups and latent positively charged groups in the copolymers useful in the present invention can be converted to charged groups upon exposure to an oxidant, a reductant, heat, light, an acid, a base, an enzyme, or electromagnetic field.
- The negatively charged repeating unit maybe a repeating unit having a negatively charged pendant group or a repeating unit having a negative charge in its monomeric backbone structure. The negatively charged pendant group can be any group with a negative charge. Representative negatively charged pendant groups include sulfuric acid groups, sulfonic acid groups, carboxylic acid groups, phosphoric acid groups, phosphonic acid groups, phenol groups, and sulfonamide groups.
- The negatively charged repeating unit can be derived from a monomer having a negatively charged pendant group or a negatively charged backbone. Representative monomers that can be used to derive the negatively charged repeating unit copolymers in the copolymers useful in the present invention include 2-carboxyethyl acrylate, 3-sulfopropyl methacrylate, lauryl methacrylate, isobutyl methacrylate, 2,2,2-trifluroethyl methacrylate, and poly(ethylene glycol) methacrylate, and D-glucuronic acid.
- The positively charged repeating unit may be a repeating unit having a positively charged pendant group or a repeating unit having a positive charge on its monomeric backbone structure. The positively charged pendant group can be any group with a positive charge. Representative positively charged pendant groups include quaternary ammonium groups, primary amine groups, secondary amine groups, tertiary amine groups, quaternary phosphonium groups, tertiary phosphonium groups, amide groups, heteroaromatic nitrogen groups, sulfonium groups, and metallic organic acids.
- The positively charged repeating unit can be derived from a monomer having a positively charged pendant group or a positively charged backbone. Representative monomers that can be used to derive the positively charged repeating unit in the copolymers useful in the present invention include 2-(dimethylamino)ethyl methacrylate, 2-(diethylamino)ethyl methacrylate, [2-(methacryloyloxy)ethyl] trimethylammonium chloride, and N-acetylglucosamine.
- It will be appreciated that the polymerizable zwitterionic monomer, the polymerizable negatively charged monomers, and the polymerizable positively charged monomers, can be non-charged (e.g., protected) monomers in which the non-charged monomers can be polymerized as described herein and then further reacted (e.g., by chemical stimuli or environmental stimuli, such as pH) to reveal the counterpart zwitterionic, negatively charged, or positively charged moieties in the product zwitterionic polymers. Such non-charged monomers are considered to be latent monomers that reveal their zwitterionic, negatively charged, or positively charged counterparts.
- Representative non-charged (latent) monomers are described in U.S. Pat. Nos. 8,268,301 and 8,349,966, each expressly incorporated herein by reference in its entirety, as well as herein.
- In another embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first chemical polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties; and
- (b) a second chemical polymeric network comprising a second zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- In this embodiment, it will be appreciated that the first crosslinked zwitterionic polymer is a chemically crosslinked zwitterionic polymer, and that the second crosslinked zwitterionic polymer is a chemically crosslinked zwitterionic polymer.
- As used herein, the term “chemical polymeric network” refers to a polymeric network that is prepared by a chemical method; specifically by polymerization. In the double network of the invention, each of the first and second network is prepared by polymerization. More specifically, once the first chemical polymeric network is prepared, a second chemical polymeric network is prepared by polymerizing a suitable polymerizable monomer (or copolymerizing suitable comonomers) in the presence of the first polymeric network (e.g., polymerizing the suitable polymerizable monomer in a solution that includes first polymeric network). Chemical polymeric networks are distinguished from physical networks, which are prepared from polymers (or copolymers) by mechanical means and include interpolymer crosslinking, such as ionic, hydrogen bonding, and dipole-dipole crosslinking. Accordingly, double networks can be chemical-chemical networks, chemical-physical networks, or physical-physical networks. Physical, chemical, and chemical-physical double networks of zwitterionic hydrogels are described in Jiang et al., J. Phys. Chem. B 2008, 112: 5327-5332.
- In a further embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties, wherein the first crosslinked zwitterionic polymer is not a poly(sulfobetaine); and
- (b) a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties.
- In another embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked polymer, wherein the first polymeric network is a hydrogel; and
- (b) a second polymeric network comprising a second crosslinked zwitterionic polymer having from about 50 to about 100 mole percent zwitterionic moieties,
- wherein the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa.
- In certain of these embodiments, the first crosslinked polymer is a zwitterionic polymer, a polysaccharide, or a collagen. Representative first crosslinked polymers include hyaluronic acids, alginates, or dextrans.
- In this embodiment, the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa. In certain of these embodiments, the compressive fracture stress of greater than about 2, 3, 5, 8, 10, 12, or 15 MPa.
- It will be appreciated that although the double network hydrogel has a compressive fracture stress of greater than about 0.9 MPa, the double network hydrogel may also be characterized as having a tensile fracture stress greater than about 0.3 MPa (e.g., greater than about 0.5, 0.7, or 1.0 MPa), a tensile fracture strain greater than about 200% (e.g., greater than about 250% or 300%), or a Young's modulus greater than about 0.01 MPa (e.g., greater than about 0.1, 0.5, 1.0 MPa).
- In a further embodiment, the zwitterionic double network hydrogel is a double network hydrogel, comprising:
- (a) a first polymeric network comprising a first crosslinked polymer, wherein the first polymeric network is a hydrogel; and
- (b) a second polymeric network comprising a crosslinked poly(sulfobetaine) having from about 50 to about 100 mole percent zwitterionic moieties.
- In certain of these embodiments, the first crosslinked polymer is a zwitterionic polymer, a polysaccharide, or a collagen. Representative first crosslinked polymers include hyaluronic acids, alginates, or dextrans.
- In certain of the double network hydrogels described above, the first crosslinked zwitterionic polymer is a poly(carboxybetaine) (pCB), poly(sulfobetaine) (pSB), poly(sulfabetaine) (pSAB), poly(phosphobetaine) (pPB), poly(phosphorylcholine) (pPC), poly(choline phosphate) (pCP), poly(trimethylamine-N-oxide) (pTMAO), or a latent derivative thereof.
- In certain of the double network hydrogels described above, the second crosslinked zwitterionic polymer is a poly(carboxybetaine) (pCB), poly(sulfobetaine) (pSB), poly(sulfabetaine) (pSAB), poly(phosphobetaine) (pPB), poly(phosphorylcholine) (pPC), poly(choline phosphate) (pCP), poly(trimethylamine-N-oxide) (pTMAO), or a latent derivative thereof.
- In certain of the double network hydrogels described above, the first crosslinked zwitterionic polymer is a poly(carboxybetaine) (pCB) and the second crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB).
- In certain of the double network hydrogels described above, the first crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB) and the second crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB).
- In certain of the double network hydrogels described above, the first crosslinked zwitterionic polymer is a poly(trimethylamine-N-oxide) (pTMAO) and the second crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB).
- In certain of the double network hydrogels described above, the first crosslinked zwitterionic polymer is a poly(phosphorylcholine) (pPC) and the second crosslinked zwitterionic polymer is a poly(sulfobetaine) (pSB).
- In certain of the double network hydrogels described above, the first crosslinked polymer is a zwitterionic polymer crosslinked with a metal ion selected from Fe3+, Ca2+, Mg2+, Cu2+, and Zn2+.
- In certain of the double network hydrogels described above, the second crosslinked zwitterionic polymer is a poly(sulfobetaine).
- In certain of the above embodiments, the zwitterionic moieties are selected from —N(CH3)3 + and —SO3 −, or —N(CH3)3 + and −SO4 −.
- The zwitterionic double network hydrogels described herein have advantageous mechanical strength characterized as having one or more of a compressive fracture stress greater than about 0.9 MPa (e.g., greater than about 2, 3, 5, 8, 10, 12, or 15 MPa); a tensile fracture stress greater than about 0.3 MPa (e.g., greater than about 0.5, 0.7, or 1.0 MPa); a tensile fracture strain greater than about 200% (e.g., greater than about 250% or 300%); or a Young's modulus greater than about 0.01 MPa (e.g., greater than about 0.1, 0.5, or 1.0 MPa).
- For the zwitterionic double network hydrogels described herein, in certain embodiments, the first polymeric network is chemically crosslinked or physically crosslinked, and the second polymeric network is chemically crosslinked or physically crosslinked. As used herein, the term “physically crosslinked” refers to crosslinking between polymers through ionic interactions, hydrogen bonding interactions, and/or dipole-dipole interactions.
- The zwitterionic double network hydrogels described herein have advantageous nonfouling properties characterized as having a fibrinogen binding level of less than about 20% (e.g., less than about 15% or less than about 10%) relative to that of tissue culture polystyrene (TCPS) tested via a fibrinogen binding assay (wherein the polymer surface is incubated at 37° C. for 90 minutes with a 1.0 mg/mL fibrinogen solution in 0.15 M phosphate buffered saline at pH 7.4).
- The zwitterionic double network hydrogels described herein have water contents greater than about 50% (e.g., greater than about 70%, 80%, or 90%) and low or no swelling (i.e., a swelling ratio, V2e/V2, less than 2, where V2 is the volume of ZDN hydrogel in the as-prepared state and V2e is the volume of ZDN hydrogel soaked in DI water or 0.15 M phosphate buffered saline at pH 7.4 until equilibrium is reached).
- As described herein, in certain embodiments, the zwitterionic double network hydrogels have at least 50 mole percent zwitterionic moieties (e.g., 60, 70, 80, 90, 100 mole percent). Higher zwitterionic content is preferred for imparting nonfouling properties to the hydrogel as long as the advantageous mechanical properties are achieved.
- In general, for the zwitterionic double network hydrogels of the invention, the first network is relatively heavily crosslinked compared to the second network, which is relatively lightly crosslinked. In certain embodiments, the zwitterionic double network hydrogels of the invention can be defined as containing 2-15 mass % first network (e.g., pCB) and 85-98 mass % second network (e.g., pSB), as shown in
FIG. 4 (given as mass %). - As described herein, the zwitterionic double network (ZDN) hydrogels of the invention are designated by the polymerization conditions for each of the first and second hydrogel networks: monomer molality-crosslinker mol %-initiator mol % (mol % based on polymerizable zwitterionic monomer or comonomers). For example, for a first network, a representative designation is 1-4-0.1; for a second network, a representative designation is 4-0.1-0.01; and for such a first and second network, the representative double network is designated 1-4-0.1/4-0.1-0.01.
- As used herein, the term “monomer molality” refers to moles of monomer per kilogram of solvent of the solution used to prepare the first and second polymer networks.
- As set forth above, for the zwitterionic double network hydrogels of the invention, the first network is relatively heavily crosslinked comparted to the second network, which is relatively lightly crosslinked. In a representative embodiment, the first network (1-4-0.1) has 4% crosslinker, which is considered to be a relatively high crosslinking density, to provide elasticity (or hardness), and the second network (4-0.1-0.01) has 0.1 mol % crosslinker, which is considered to be a relatively low crosslinking density, to provide viscosity (or softness). The combination of these two properties (elasticity/hardness and viscosity/softness) results in the high strength of the ZDN hydrogels of the invention.
- Moreover, the second network provides a locking effect and is the majority of the ZDN hydrogel based on mass (amount to about 85 to 95 mol % of the whole ZDN hydrogel).
- The following is a summary of monomer molality-crosslinker mol %-initiator mol % (mol % based on polymerizable zwitterionic monomer or comonomers) for representative ZDN hydrogels of the invention. In certain embodiments of the first network: [1-10]-[1-50]-[0.1-1]. In other embodiments of the first network: [1-2]-[2-4]-0.1. In one embodiment of the first network: 1-4-0.1. In certain embodiments of the second network: [1-10]-[0-10]-[0.01-1]. In other embodiments of the second network: [2-6]-[0-0.5]-0.01. In one embodiment of the second network: 4-0.1-0.01.
- The following is a summary of monomer molality-crosslinker mol %-initiator mol % (mol % based on polymerizable zwitterionic monomer or comonomers) for representative ZDN hydrogels of the invention: first network poly(carboxybetaine), second network poly(sulfobetaine). In certain embodiments of the first network: [1-3]-[2-50]-[0.1-1]. In other embodiments of the first network: [1-2]-[2-4]-0.1. In one embodiment of the first network: 1-4-0.1. In certain embodiments of the second network: [2-10]-[0-0.5]-[0.01-1]. In other embodiments of the second network: [2-6]-[0-0.5]-0.01. In one embodiment of the second network: 4-0.1-0.01. For representative pCB/pSB ZDN hydrogels: [1-3]-[2-50]-[0.1-1]/[2-6]-[0-0.5]-[0.01-1]. For a representative pCB/pSB ZDN hydrogel: 1-4-0.1/4-0.1-0.01.
- In certain embodiments of the ZDN hydrogels described herein, the first network has a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-10]-[1-50]-[0.1-1]. In certain of these embodiments, the first network has a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-2]-[2-4]-0.1.
- In certain embodiments of the ZDN hydrogels described herein, the second network has a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-10]-[0-10]-[0.01-1]. In certain of these embodiments, the second network has a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [2-6]-[0-0.5]-0.01.
- In certain embodiments of the ZDN hydrogels described herein, the first network is a poly(carboxybetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-2]-[2-4]-[0.1]. In certain of these embodiments, the first network is a poly(carboxybetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about 1-4-0.1.
- In certain embodiments of the ZDN hydrogels described herein, the second network is a poly(sulfobetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [2-6]-[0-0.5]-[0.01-1]. In certain of these embodiments, the second network is a poly(sulfobetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about 4-0.1-0.01.
- In certain embodiments of the ZDN hydrogels described herein, the first network is a poly(carboxybetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [1-3]-[2-50]-[0.1-1], and the second network is a poly(sulfobetaine) network having a ratio of [monomer molality]-[crosslinker mol %]-[initiator mol %], wherein mol % is based on polymerizable zwitterionic monomer or comonomers, of about [2-6]-[0-0.5]-[0.01-1].
- Methods for Making Zwitterionic Double Network Hydrogels
- In certain embodiments, the zwitterionic double network hydrogels described herein can be obtained by a two-step process in which the first polymeric network is formed (e.g., by polymerization of zwitterionic monomers, crosslinking agents, and initiators, as necessary; copolymerization of zwitterionic and non-zwitterionic comonomers, crosslinking agents, and initiators, as necessary; or physical crosslinking of zwitterionic polymers or zwitterionic copolymers) and then soaked to equilibrium in a solution comprising precursors of the second polymeric network (e.g., zwitterionic monomers, crosslinking agents, and initiators, as necessary; zwitterionic and non-zwitterionic comonomers, crosslinking agents, and initiators, as necessary; or zwitterionic polymers or zwitterionic copolymers, and physical crosslinking agents), and the resulting first polymer network and the precursors of the second polymeric network are subject to polymerization conditions suitable to effect polymerization and formation of the second network and consequently the double network hydrogel.
- In other embodiments, the zwitterionic double network hydrogels described herein can be obtained by a one-step (e.g., single pot) process, wherein the second polymeric network is formed in the presence of the first polymeric network. In the one-step (e.g., single pot) process, the second polymeric network is formed by (a) zwitterionic monomer polymerization (e.g., polymerization of monomer, crosslinking agent, and initiator), (b) zwitterionic and non-zwitterionic comonomer polymerization (e.g., copolymerization of comonomers, crosslinking agent, and initiator), or (c) physical crosslinking of a zwitterionic polymer or a zwitterionic copolymer (e.g., physical crosslinking of zwitterionic polymer or zwitterionic copolymer and physical crosslinking agent) in the presence of the first polymeric network.
- Articles of Manufacture from Zwitterionic Double Network Hydrogels
- In another aspect, the invention provides articles of manufacture comprising, in whole or in part, a zwitterionic double network hydrogel described herein.
- In one embodiment, the article is a biomedical device. Representative biomedical devices include catheters, ear drainage tubes, feeding tubes, glaucoma drainage tubes, hydrocephalous shunts, keratoprosthesis, nerve guidance tubes, tissue adhesives, x-ray guides, artificial joints, artificial heart valves, artificial blood vessels, pacemakers, left ventricular assist devices (LVAD), artery grafts, vascular grafts, stents, intravascular stents, cardiac valves, joint replacements, blood vessel prostheses, skin repair devices, cochlear replacements, contact lenses, artificial ligaments and tendons, dental implants, and tissue scaffolds for regenerative tissue engineering.
- In another embodiment, the article is a consumer product. Representative consumer products include wound dressings or wound care devices, skin sealants, dermatology devices (skin repair devices, bandages), cosmetic devices or formulations (topical creams, topical masks, injectable or implantable gels or other formulation for aesthetic, reconstructive or rejuvenation purposes), contact lens, OB/Gyn devices (implantable or topical birth control devices, vaginal slings), intra-ocular lens, aesthetic implants (breast implants, nasal implants, cheek implants), hormone control implants (blood sugar sensors, insulin pumps), urology devices (catheters, artificial urethrae).
- In a further embodiment, the article is a marine product. Representative marine products include, in whole or in part, marine vessel hulls, marine structures, bridges, propellers, heat exchangers, periscopes, sensors, fish nets, cables, tubes/pipes, containers, membranes, and oil booms.
- In another embodiment, the invention provides a microgel, comprising a zwitterionic double network hydrogel described herein.
- In a further embodiment, the invention provides a surface coating for a substrate, comprising a zwitterionic double network hydrogel described herein. All or part of a surface of the substrate may be coated with the zwitterionic double network hydrogel.
- In one embodiment, the substrate is a biomedical device. Representative biomedical devices include those listed above.
- In another embodiment, the substrate is a consumer product. Representative consumer products include those listed above.
- In a further embodiment, the substrate is a marine product. Representative marine products include those listed above.
- As used herein, the term “about” refers to ±5% of the recited value.
- The following examples are provided for the purpose of illustrating, not limiting, the invention.
- In this example, the preparation of representative ZDN hydrogels of the invention is described.
- Preparation of pCB/pSB ZDN hydrogels. ZDN hydrogels were synthesized by a two-step sequential free-radical polymerization. In the first step, the first network poly{3-[3-(acrylamidopropyl)dimethylammonio]propionate} (pCB) hydrogels were synthesized by photopolymerization using 1 m (molality) of CB, 4 mol % of crosslinker N,N-methylenebis(acrylamide) (MBAA), and 0.1 mol % of initiator 2-hydroxy-2-methylpropiophenone (1173) (both were relative to the CB monomer) in a transparent sheet molds or tubular rod molds under an ultraviolet (UV) irradiation with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket. The polymerization condition of the first network hydrogel is denoted as 1-4-0.1 (CB molality-crosslinker mol %-initiator mol %). In the second step, the as-prepared pCB hydrogel was immersed into the precursor solution of second network containing 4 m of [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (SB), 0.1 mol % of MBAA and 0.01 mol % of initiator 1173 (both were relative to the SB monomer) for 24 h. The polymerization condition of the second network hydrogel is denoted as 4-0.1-0.01 (SB molality-crosslinker mol %-initiator mol %). Hence the polymerization condition of ZDN hydrogel is denoted as 1-4-0.1/4-0.1-0.01. The fully swollen first network hydrogel containing the precursor solution of second network is further polymerized by UV irradiation with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket. After this two-step synthesis, the as-prepared pCB/pSB ZDN hydrogels were immersed in an aqueous solution for 1 day until they reached swelling equilibrium. In addition to 1-4-0.1/4-0.1-0.01, different combination of first network (1-2-0.1 and 2-4-0.1) and second network (4-0-0.01, 4-0.01-0.01, 4-0.2-0.01, 4-0.5-0.01, 2-0.1-0.01 and 6-0.1-0.01) were used for the synthesis of ZDN hydrogels.
- Preparation of pCB/pCB, pCB/pSB, and pSB/pSB ZDN hydrogels. ZDN hydrogels were prepared according to the methods described above. In addition to 1-4-0.1/4-0.1-0.01, different combination of first network (1-2-0.1 and 2-4-0.1) and second network (4-0-0.01, 4-0.01-0.01, 4-0.2-0.01, 4-0.5-0.01, 2-0.1-0.01 and 6-0.1-0.01) were used for the synthesis of ZDN hydrogels.
- In this example, equilibrium swelling ratio, equilibrium water content, and mass percentage tests used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel, are described.
- The equilibrium swelling ratio (ESR) of equilibrated ZDN hydrogels to their as-prepared state was evaluated via a dimension measurement method. The as-prepared ZDN hydrogel disks were cut by a biopsy punch (5 or 10 mm in diameter). The diameters (r1) and heights (h1) of as-prepared ZDN hydrogel disks were measured and then soaked in deionized water at 37° C. for 2 days for completely swelling. The diameters (r2) and heights (h2) of their corresponding equilibrated state were measured. The ESRs were calculated as below. Each measurement was performed in triplicate.
-
- The equilibrium water content (EWC) of ZDN hydrogels was measured through a gravimetric method. ZDN hydrogel disks (10 mm in diameter and 1 mm in thickness) were allowed to swell in deionized water until reaching equilibrium at 37° C. The equilibrated samples were taken out and their wet mass (Mw) were measured after the removal of excess water on the surface by rolling them on filter papers. The samples were then snap-frozen in liquid nitrogen and lyophilized for 2 days until a complete dryness and their dry mass (Md) were measured. The EWCs were calculated as below. Each measurement was performed in triplicate.
-
- The first network hydrogel were allowed to swell in deionized water until reaching equilibrium at 37° C. Their dry mass (MO were acquired after snap-frozen in liquid nitrogen and lyophilized for 2 days. The mass percentages (MS) of first network hydrogel were calculated as below. Each measurement was performed in triplicate.
-
- In this example, compression and tensile tests used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel, are described.
- Compressive and tensile tests were performed by a tensile-compressive mechanical tester (Instron 5543A, Instron Corp., Norwood, Mass.) with a 1 kN load cell to record the mechanical properties of the equilibrated pCB/pSB ZDN hydrogel samples. For tensile tests, crosshead speed was set at 10 mm min−1. The equilibrium sheet samples were cut into rectangular pieces with dimensions of 20 mm×2 mm×0.50 mm. For compressive tests, the crosshead speed was set at 1 mm min−1. The equilibrium tubular rod samples were cut with diameter and height of 5 and 3.5 to 4 mm, respectively. Average data were acquired by testing five specimens for each sample. The equilibrated pCB/pSB ZDN hydrogel had compressive fracture stress more than 15 MPa and stayed intact with 99% of compressive strain measured by compression test. The equilibrated pCB/pSB ZDN hydrogel had tensile fracture stress about 1 MPa and tensile fracture strain more than 300% measured by tensile test.
- In this example, a fibrinogen adsorption test used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- Fibrinogen (Fg) was chosen as the test protein to examine the nonfouling property of the ZDN samples. To measure Fg adhesion, the equilibrated pCB/pSB ZDN hydrogel samples were first incubated with 1 mL of 1 mg mL−1 Fg in 0.15 M phosphate buffered saline (PBS) buffer at pH 7.4 for 1.5 hours, followed by 5 washes with pure PBS buffer. Samples were then transferred to new wells and incubated with 1 mL of horseradish peroxidase (HRP) conjugated anti-fibrinogen (1 μg mL−1) in PBS buffer for 1.5 hours. All samples were then transferred to new wells after another 5 washes with pure PBS buffer. Next, 1 mL of 1 mg mL−1 o-phenylenediamine (OPD) 0.1 M citrate phosphate pH 5.0 solution, containing 0.03% hydrogen peroxide was added. After 15 min incubation, the enzymatic reaction was stopped by adding an equal volume of 1N HCl. Absorbance value at 492 nm was recorded by a plate reader (
Cytation 3, BioTek, Winooski, Vt.), and was normalized to that of tissue culture polystyrene (TCPS) sample. Average data were acquired from three specimens. The equilibrated pCB/pSB ZDN hydrogel sample were tested to have a fibrinogen binding level of less than 10% relative to that of TCPS. - In this example, a serum adsorption test by micro-BCA assay used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- Human serum fouling of the ZDN hydrogels was evaluated via a micro-BCA method. Pre-equilibrated ZDN hydrogel disks in PBS (5 mm in diameter and 1 mm in thickness) were suspended into 400 μL of undiluted human pooled serum in 24-well TCPS followed by incubation at 37° C. for 2 h. Before being transferred into new wells, all the samples were rinsed with 1 mL of PBS five times to remove the dissociative proteins. A micro-BCA assay was then directly carried out to determine the amount of proteins adsorbed on the hydrogel and the absorbance values at 562 nm of all the samples were recorded by a plate reader and were normalized to that of TCPS (96-well, control). Each sample was measured in triplicate.
- In this example, a platelet attachment analysis by lactate dehydrogenase assay used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- Platelets used for adhesion analysis were freshly collected from the blood of Sprague Dawley (SD) rats. Fresh blood collected was then immediately centrifuged at 200 g for 10 min to get platelet rich plasma (PRP). The residue was further centrifuged at 2000 g for 20 min to obtain platelet poor plasma (PPP). PRP and PPP were gently remixed and the final platelet density was adjusted to 2×108 mL−1. Pre-equilibrated hydrogel disks in PBS (5 mm in diameter and 1 mm in thickness) were placed in 24-well TCPS with one disk per well, immersed with 400 μL of final platelet solution and incubated at 37° C. for 3 h. After incubation, the disks were rinsed with 1 mL of PBS five times and then transferred into new wells. The number of adhered platelets was determined by the lactate dehydrogenase (LDH) assay. For LDH assay, the rinsed samples were soaked in 24-well TCPS with 300 μL PBS and 10
μL 10× lysis buffer and incubated at 37° C., 5% carbon dioxide for 45 minutes. 50 μL reaction mixtures were then added into each well and incubated at room temperature for 30 minutes in the dark. To stop the reaction, 50 μL stop solution was added to each well and mixed by gentle pipetting. Finally 200 μL of the mixture was taken out from each well and the absorbance at 490 nm and 680 nm was measured by a platelet reader. The LDH activity was determined by subtracting the absorbance value of 680 nm from that of the 490 nm. Data were normalized to that of TCPS (96-well, control). Each sample was measured in triplicate. - In this example, a cell attachment assay used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- Rat pancreatic β cells RIN-m5F and murine DC 2.4 dendritic cells were selected for the cell adhesion assay of the hydrogels. In brief, PBS pre-equilibrated and UV sterilized hydrogels disks (5 mm in diameter and 1 mm in thickness) were placed individually into the wells of a 96-well plate. RIN-m5F or DC 2.4 cells suspended in corresponding culture medium were seeded onto the hydrogels at a density of 1×105 cells/mL or 5×104 cells/mL, respectively, and allowed to grow for 24 h at 37° C. in a humidified atmosphere with 5% carbon dioxide. The medium was then removed and the hydrogels were gently washed with PBS and re-immersed with PBS. For optical imaging, cells adhesion and cellular morphology on the samples were observed at 400× magnification using a microscope (Nikon Eclipse 80i). For quantitative analysis of adhered cells, the samples were gently transferred to new wells and then the LDH assay was carried out following the protocol as described above. All the data were normalized to that of TCPS (96-well, control). Each sample was measured in sextuplicate.
- In this example, pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01) were sterilized via a standard autoclaving method.
- As-prepared pCB/pSB ZDN hydrogels were soaked in water or PBS until equilibrium and then sterilized at 121° C. for 30 min together with corresponding soaking solutions. The sterilized hydrogels were then cooled to room temperature for further use or test. Hydrogels experienced one, two, or three rounds of such heating-cooling autoclaving sterilization process were named as ZDN-R1, ZDN-R2 and ZDN-R3, respectively. The subsequent mechanical property, protein adhesion and cell adhesion tests of autoclaved ZDN hydrogels all followed the protocols described as above.
- In this example, in vivo implantation of representative pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01) sheets is described.
- Six to eight-week-old male C57BL/6 mice were purchased from Charles River Labs. All the animal experiments were operated according to the federal guidelines and were approved by the University of Washington Animal Care and Use Committee. Subcutaneous implantation experiments were carried out to evaluate the foreign-body reaction and fibrous capsule formation of pCB/pSB ZDN hydrogels. Square pCB/pSB ZDN hydrogel disks (10 mm×10 mm×1 mm) were sterilized by autoclaving prior to implantation to prevent bacterial infection. pHEMA hydrogels with the same shape and dimension were set as positive control and were sterilized with UV for 30 min before surgery. The animal surgery was performed under anesthesia and aseptic conditions. In brief, each mouse was subcutaneously implanted with two ZDN or two pHEMA hydrogels symmetrically on the back with one sample on each side. Mice were anesthetized using 3% isoflurane and shaved. The area where the incision would be made was sterilized using iodine and 70% ethanol. A longitudinal incision (no longer than 1 cm) was made on the central dorsal surface using surgical scissors to provide access to the subcutaneous space. Subcutaneous pockets on either side of the incision were created with a blunt forceps for the implantation of the hydrogel samples. After implantation, the incisions were closed using wound nylon sutures and analgesic (Meloxicam) was administered. Twelve replicates of each type of hydrogel were implanted into six different mice to provide statistical significance in the histological studies. Mice were monitored until recovery from anesthesia and housed for 1 week, 4 weeks, 12 weeks, or 24 weeks before retrieving samples.
- In this example, the preparation representative zwitterionic double network (ZDN) microgels of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- ZDN microgels were produced using a stainless-steel piston and cylinder apparatus, where bulk hydrogels of the invention, pCB/pSB ZDN hydrogels (1-4-0.1/4-0.1-0.01), were extruded through progressively finer micronic steel meshes (TWP; 500 μm down to 25 μm pores). Microgels were passed through the final mesh size five times for size homogeneity.
- In this example, ulva spore attachment and adhesion tests used to measure the properties of a representative representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01) is described.
- Attachment of spores. Zoospores were obtained from mature plants of U. linza by the standard method. A suspension of zoospores (15 ml; 7.5×105 spores ml−1) was added to individual compartments of quadriPERM dishes containing the samples. After 45 minutes in darkness at about 20° C., the slides were observed under the microscope to determine whether there was any settlement on the surfaces. The samples were then washed by moving back and forth under seawater to remove unsettled (i.e., swimming) spores. Care was taken that the samples did not move through the air water interface. The samples were again viewed through the microscope and counts of spores were made on the wet samples. The density of zoospores attached to the surfaces was counted on each of 3 replicate slides using an image analysis system attached to a fluorescence microscope. Spores were visualised by autofluorescence of chlorophyll. Counts were made for 30 fields of view (each 0.15 mm2) on each slide.
- Strength of attachment of spores. After counting in the wet state, the spores attached to the coatings were 3 hours old (compared to 45 minutes in a standard assay). The slides, with attached spores, were exposed to a shear stress of 52 Pa in a specially designed turbulent flow water channel. Slides were then recounted in the wet state as described above.
- In this example, N. incerta diatom attachment and adhesion tests used to measure the properties of a representative zwitterionic double network (ZDN) hydrogel of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01), is described.
- Attachment of diatom. Cells of N. incerta were cultured in F/2 medium contained in 250 ml conical flasks. After 3 days the cells were in log phase growth. Cells were washed 3 times in fresh medium before harvesting and diluted to give a suspension with a chlorophyll a content of approximately 0.2 μg ml−1. Cells were settled on three replicate coated slides of each sample, in individual quadriPERM® dishes containing 15 ml of suspension, at about 20° C. on the laboratory bench. After 2 hours the slides were exposed to 5 minutes of shaking on an orbital shaker (60 rpm) followed by a submerged wash in seawater to remove cells that had not attached (the immersion process avoided passing the samples through the air-water interface). Three slides of each type were counted, whilst still wet, using an image analysis system attached to a fluorescence microscope. Cells were visualised by autofluorescence of chlorophyll. Counts were made for 30 fields of view (each 0.56 mm2) on each slide.
- Strength of attachment of diatom. After counting, the slides with attached cells were exposed to a shear stress of 26 Pa in a water channel for 5 minutes. The number of cells remaining attached was counted wet as described above.
- In this example, the single-pot method for preparing a representative zwitterionic double network (ZDN) hydrogel coating of the invention, pCB/pSB ZDN hydrogel (1-4-0.1/4-0.1-0.01) coating, is described.
- The single-pot procedure was conducted by simply mixing zwitterionic pCB polymers, Ca2+ ions, SB monomer, MBAA crosslinker, 1173 photo-reactive initiator and DI water in single container. The pCB interacted with Ca2+ ions (ionic bonding) and formed the first network, followed by photo-initiating polymerization of SB via exposing to UV with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket. The as-prepared ZDN hydrogel was immersed in DI water and the swelling ratio V2e/V2, is less than 2, where V2 is the volume of ZDN hydrogel in the as-prepared state and Vee is the volume of ZDN hydrogel soaked in DI water until equilibrium.
- The hybrid (physically and chemically) crosslinked pCB/pSB ZDN hydrogel was successfully formed via single-pot method. In addition to Ca2+, Mg2+, Cu2+, and Fe3+, were used respectively to interact with pCB to successfully form the first network via the ionic bonding.
- In this example, the preparation and characteristics of representative zwitterionic double network (ZDN) hydrogels of the invention, pTMAO/pSB ZDN hydrogels, are described.
- pTMAO/pSB ZDN hydrogels were synthesized by a two-step sequential free-radical polymerization. In the first step, the first network poly(trimethylamine-N-oxide) (pTMAO) hydrogels were synthesized by photo polymerization using 1 m of TMAO, 4 mol % of cross-linker N,N-methylenebis(acrylamide) (MBAA), and 0.1 mol % of initiator 2-hydroxy-2-methylpropiophenone (1173) (both were relative to the TMAO monomer) in a transparent sheet molds or tubular rod molds under an ultraviolet (UV) irradiation with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket. In the second step, the as-prepared pTMAO hydrogel was immersed into the precursor solution of second network containing 4 m of [2-(methacryloyloxy)ethyl]dimethyl-(3-sulfopropyl)ammonium hydroxide (SB), 0.1 mol % of MBAA and 0.01 mol % of initiator 1173 (both were relative to the SB monomer) for 2 days. The fully swollen first network hydrogel containing the precursor solution of second network is further polymerized by UV irradiation with wavelength 305 nm and 6 watt power for 6 h in a nitrogen blanket. After this two-step synthesis, the as-prepared pTMAO/pSB ZDN hydrogels were immersed in an aqueous solution for 1 day until they reached swelling equilibrium. The equilibrated pTMAO/pSB ZDN hydrogel had low swelling behavior in DI water with only 7% volume increase compared to that of the pTMAO/pSB ZDN hydrogel in the as-prepared state.
- Compressive and tensile tests were performed by a tensile-compressive mechanical tester (Instron 5543A, Instron Corp., Norwood, Mass.) with a 10 kN load cell to record the mechanical properties of the equilibrated pTMAO/pSB ZDN hydrogel samples. For tensile tests, crosshead speed was set at 10 mm min−1. The equilibrium sheet samples were cut into rectangular pieces with dimensions of 20 mm×2 mm×0.50 mm. For compressive tests, the crosshead speed was set at 1 mm min−1. The equilibrium tubular rod samples were cut with diameter and height of 5 and 3.5 to 4 mm respectively. Average data were acquired by testing five specimens for each sample. The equilibrated pTMAO/pSB ZDN hydrogel had compressive fracture stress more than 10 MPa and stayed intact with 95% of compressive strain measured by compression test.
- While illustrative embodiments have been illustrated and described, it will be appreciated that various changes can be made therein without departing from the spirit and scope of the invention.
Claims (46)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/268,310 US20210171783A1 (en) | 2018-08-14 | 2019-08-14 | Zwitteronic double network hydrogels |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862718759P | 2018-08-14 | 2018-08-14 | |
US201962818574P | 2019-03-14 | 2019-03-14 | |
PCT/US2019/046558 WO2020106338A2 (en) | 2018-08-14 | 2019-08-14 | Zwitterionic double network hydrogels |
US17/268,310 US20210171783A1 (en) | 2018-08-14 | 2019-08-14 | Zwitteronic double network hydrogels |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210171783A1 true US20210171783A1 (en) | 2021-06-10 |
Family
ID=70773580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/268,310 Pending US20210171783A1 (en) | 2018-08-14 | 2019-08-14 | Zwitteronic double network hydrogels |
Country Status (5)
Country | Link |
---|---|
US (1) | US20210171783A1 (en) |
EP (1) | EP3836969A4 (en) |
JP (1) | JP2021533892A (en) |
CN (1) | CN112805033A (en) |
WO (1) | WO2020106338A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114027392A (en) * | 2021-11-22 | 2022-02-11 | 江南大学 | Double-network pea protein hydrogel with high freeze-thaw stability and preparation method thereof |
CN114957721A (en) * | 2022-05-30 | 2022-08-30 | 四川大学 | Zwitterionic hydrogel and preparation method and application thereof |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022047203A1 (en) * | 2020-08-28 | 2022-03-03 | The Board Of Regents For Oklahoma Agricultural And Mechanical Colleges | Zwitterionic hydrogels and methods of making and using same for protein therapy |
CN113577395B (en) * | 2021-07-07 | 2023-01-13 | 天津大学 | Hydrogel artificial blood vessel and preparation method thereof |
CN113861320A (en) * | 2021-09-26 | 2021-12-31 | 哈尔滨工业大学(深圳) | Anti-freezing hydrogel, preparation method and application |
CN114344571B (en) * | 2021-12-13 | 2022-09-16 | 中国科学院宁波材料技术与工程研究所 | Antibacterial material and preparation method and application thereof |
TWI802291B (en) * | 2022-02-23 | 2023-05-11 | 國立清華大學 | Highly compressible shape memory double network hydrogel, use and preparation method thereof, and intervertebral disk scaffold |
CN115299445B (en) * | 2022-10-08 | 2023-02-03 | 云南省烟草公司昆明市公司 | Compound solution for improving induced disease resistance of lentinan to plants, preparation method and method thereof, and method for preventing and controlling viruses in plants in field |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6085075B2 (en) * | 2005-08-25 | 2017-02-22 | ユニヴァーシティ オブ ワシントン | Ultra-low fouling sulfobetaine and carboxybetaine materials and related methods |
JP6067376B2 (en) * | 2009-11-06 | 2017-01-25 | ユニヴァーシティ・オブ・ワシントン・スルー・イッツ・センター・フォー・コマーシャリゼーション | Cross-linked zwitterionic hydrogel |
EP2526150B1 (en) * | 2010-01-22 | 2018-04-25 | FPInnovations | Nanocomposite hydrogel and method for preparing it, for industrial and medical applications |
WO2017027088A2 (en) * | 2015-06-03 | 2017-02-16 | Massachusetts Institute Of Technology | Multifunctional bonding of hydrogels |
-
2019
- 2019-08-14 JP JP2021507672A patent/JP2021533892A/en active Pending
- 2019-08-14 US US17/268,310 patent/US20210171783A1/en active Pending
- 2019-08-14 WO PCT/US2019/046558 patent/WO2020106338A2/en unknown
- 2019-08-14 CN CN201980065481.5A patent/CN112805033A/en active Pending
- 2019-08-14 EP EP19888182.3A patent/EP3836969A4/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114027392A (en) * | 2021-11-22 | 2022-02-11 | 江南大学 | Double-network pea protein hydrogel with high freeze-thaw stability and preparation method thereof |
CN114957721A (en) * | 2022-05-30 | 2022-08-30 | 四川大学 | Zwitterionic hydrogel and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2020106338A2 (en) | 2020-05-28 |
EP3836969A2 (en) | 2021-06-23 |
EP3836969A4 (en) | 2022-06-01 |
JP2021533892A (en) | 2021-12-09 |
WO2020106338A3 (en) | 2020-07-02 |
CN112805033A (en) | 2021-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210171783A1 (en) | Zwitteronic double network hydrogels | |
US9738780B2 (en) | Crosslinked mixed charge hydrogels | |
US10828398B2 (en) | Functionalized zwitterionic and mixed charge polymers, related hydrogels, and methods for their use | |
Abraham et al. | Molecularly engineered p (HEMA)-based hydrogels for implant biochip biocompatibility | |
US8308699B2 (en) | Layered non-fouling, antimicrobial antithrombogenic coatings | |
KR101053792B1 (en) | Biosynthetic Matrix and Uses thereof | |
JP5587612B2 (en) | Hydrophilic coating | |
EP2352797B1 (en) | Non-fouling, anti-microbial, anti-thrombogenic graft-from compositions | |
EP3261626A1 (en) | Methods and compositions relating to biocompatible implants | |
JP2013538247A (en) | Fluorinated polymer and lubricity coating | |
JPWO2009066746A1 (en) | Tissue adhesion prevention material and joint contracture prevention material | |
JP6961587B2 (en) | Slippery imparting agent and slippery imparting method | |
US20240123075A1 (en) | N-Oxide and Ectoine Monomers, Polymers, Their Compositions, and Related Methods | |
Sherman et al. | Novel polyisobutylene/polydimethylsiloxane bicomponent networks: III. Tissue compatibility | |
JP2021519275A (en) | Immunosuppressive materials and related methods | |
KR20180010565A (en) | Hydrogel with improved modulus and medical uses thereof | |
Li et al. | Physically cross-linked organo-hydrogels for friction interfaces in joint replacements: design, evaluation and potential clinical applications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNIVERSITY OF WASHINGTON, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JIANG, SHAOYI;HUNG, HSIANG-CHIEH;DONG, DIANYU;AND OTHERS;SIGNING DATES FROM 20210223 TO 20210226;REEL/FRAME:055456/0728 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |